- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 13:22:52'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 13:22:52'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: 'Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of
    NHANES 2003 to 2018 | The Journal of Clinical Endocrinology & Metabolism | Oxford
    Academic'
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 美国成年人的镁耗损评分与代谢综合征：分析NHANES 2003至2018 | 临床内分泌学与代谢杂志 | 牛津学术出版社
- en: 来源：[https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgae075/7608307](https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgae075/7608307)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgae075/7608307](https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgae075/7608307)
- en: Abstract
  id: totrans-split-6
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 摘要
- en: Context
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: 背景
- en: The association between magnesium status and metabolic syndrome (MetS) remains
    unclear.
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
  zh: 镁状态与代谢综合征（MetS）之间的关联仍不清楚。
- en: Objective
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
  zh: 目标
- en: This study aimed to examine the relationship between kidney reabsorption-related
    magnesium depletion score (MDS) and MetS among US adults.
  id: totrans-split-10
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究旨在检验肾重吸收相关的镁缺乏评分（MDS）与美国成年人MetS之间的关系。
- en: Methods
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
  zh: 方法
- en: We analyzed data from 15 565 adults participating in the National Health and
    Nutrition Examination Survey (NHANES) 2003 to 2018\. MetS was defined according
    to the National Cholesterol Education Program's Adult Treatment Panel III report.
    The MDS is a scoring system developed to predict the status of magnesium deficiency
    that fully considers the pathophysiological factors influencing the kidneys' reabsorption
    capability. Weighted univariate and multivariable logistic regression were used
    to assess the association between MDS and MetS. Restricted cubic spline (RCS)
    analysis was conducted to characterize dose-response relationships. Stratified
    analyses by sociodemographic and lifestyle factors were also performed.
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
  zh: 我们分析了参与2003至2018年国家健康与营养检查调查（NHANES）的15,565名成年人的数据。MetS根据国家胆固醇教育计划成人治疗第III报告定义。MDS是一种评分系统，旨在预测完全考虑影响肾脏重吸收能力的病理生理因素的镁缺乏状态。采用加权单变量和多变量Logistic回归分析了MDS与MetS之间的关联。进行了受限立方样条（RCS）分析以表征剂量-反应关系。还进行了根据社会人口统计和生活方式因素分层分析。
- en: Results
  id: totrans-split-13
  prefs: []
  type: TYPE_NORMAL
  zh: 结果
- en: In both univariate and multivariable analyses, higher MDS was significantly
    associated with increased odds of MetS. Each unit increase in MDS was associated
    with approximately a 30% higher risk for MetS, even after adjusting for confounding
    factors (odds ratio 1.31; 95% CI, 1.17-1.45). RCS graphs depicted a linear dose-response
    relationship across the MDS range. This positive correlation remained consistent
    across various population subgroups and exhibited no significant interaction by
    age, sex, race, adiposity, smoking status, or alcohol consumption.
  id: totrans-split-14
  prefs: []
  type: TYPE_NORMAL
  zh: 无论是单变量分析还是多变量分析，较高的MDS与代谢综合征（MetS）的概率显著相关。每增加一个MDS单位，MetS的风险增加约30%，即使在调整混杂因素后也是如此（比值比1.31；95%
    CI，1.17-1.45）。RCS图表现出MDS范围内的线性剂量-反应关系。这种正相关性在各种人群亚组中保持一致，并且在年龄、性别、种族、脂肪率、吸烟状况或饮酒情况方面没有显著交互作用。
- en: Conclusion
  id: totrans-split-15
  prefs: []
  type: TYPE_NORMAL
  zh: 结论
- en: Higher urinary magnesium loss as quantified by MDS may be an independent linear
    risk factor for MetS in US adults, irrespective of sociodemographic and behavioral
    factors. Optimizing magnesium nutritional status could potentially confer benefits
    to patients with MetS.
  id: totrans-split-16
  prefs: []
  type: TYPE_NORMAL
  zh: 通过MDS定量化的尿镁流失可能是美国成年人MetS的独立线性风险因素，无论社会人口统计和行为因素如何。优化镁营养状况可能会对患有MetS的患者带来潜在益处。
- en: 'Metabolic syndrome (MetS) is a common metabolic disorder caused by the increasing
    prevalence of obesity, and currently, this disorder is defined in various ways.
    In the 1980s, Reaven clustered the risk factors for diabetes and cardiovascular
    diseases together and called it “syndrome X,” which includes insulin resistance,
    hypertension, hyperglycemia, low high-density lipoprotein cholesterol (HDL-c),
    and high triglycerides (TGs) (1). Insulin resistance is defined clinically as
    the inability of a known quantity of exogenous or endogenous insulin to increase
    glucose uptake and utilization in an individual as much as it does in a normal
    population (2). In 1992, after central obesity was added as a core component of
    the definition and entity, it was renamed insulin resistance syndrome (IRS) (3).
    In 1998, The World Health Organization uniformly named it “metabolic syndrome”
    (MetS) and proposed that insulin resistance is the core of the pathophysiology
    of MetS (4). In the following years, the definitions of MetS revised according
    to the racial conditions of other countries also appeared, among which the more
    influential ones include the definition of the National Cholesterol Education
    Program Adult Treatment Panel III Criteria (NCEP-ATP III) (5) and the definition
    of the International Diabetes Federation. According to the NCEP ATP III definition,
    MetS is diagnosed as the presence of at least 3 of the following 5 characteristics:
    high waist circumference, high blood pressure, elevated blood sugar level, increased
    TGs, and low HDL-c (5). MetS is important because of its association with an increasing
    prevalence of diabetes and a higher risk of cardiovascular events such as heart
    disease and stroke, which have become a major public health challenge.'
  id: totrans-split-17
  prefs: []
  type: TYPE_NORMAL
  zh: 代谢综合征（MetS）是由肥胖日益普遍引起的常见代谢紊乱，目前这种紊乱有多种定义方式。上世纪80年代，里文（Reaven）将糖尿病和心血管疾病的风险因素聚集在一起，称之为“X综合征”，包括胰岛素抵抗、高血压、高血糖、低高密度脂蛋白胆固醇（HDL-c）和高甘油三酯（TGs）（1）。临床上将胰岛素抵抗定义为，已知量的外源或内源胰岛素无法像正常人群一样增加葡萄糖的摄取和利用（2）。1992年，将中心性肥胖作为定义和实体的核心组成部分之后，将其改名为胰岛素抵抗综合征（IRS）（3）。1998年，世界卫生组织统一命名为“代谢综合征”（MetS），并提出胰岛素抵抗是MetS病理生理的核心（4）。此后，根据其他国家种族情况修订了MetS的定义，其中比较有影响力的包括国家胆固醇教育项目成人治疗第三期标准（NCEP-ATP
    III）的定义（5）和国际糖尿病联盟的定义。根据NCEP ATP III的定义，MetS的诊断标准为至少具备以下5种特征中的3种：高腰围、高血压、血糖升高、TGs增加和HDL-c降低（5）。MetS的重要性在于与糖尿病日益普遍和心血管事件（如心脏病和中风）的风险增加相关，这已成为重要的公共卫生挑战。
- en: Magnesium is a vital mineral in the human body, serving as an essential cofactor
    for hundreds of enzymatic reactions. These include energy metabolism, protein
    and nucleic acid synthesis, and the secretion and action of insulin (6, 7). It
    plays a crucial role in maintaining normal nerve and muscle function, supporting
    a healthy immune system, and ensuring a steady heartbeat. Despite its importance,
    magnesium deficiency is a widespread and often overlooked public health issue.
    More than half of the US population fails to meet the recommended dietary allowance
    for magnesium intake, leading to a high estimated prevalence (∼15%) of magnesium
    deficiency (8). Studies have found that hypomagnesemia is associated with elevated
    risk and adverse prognosis in patients with diabetes, stroke, and coronary artery
    disease. Increasing magnesium intake can reduce the risk of diabetes, stroke and
    hypertension (9, 10).
  id: totrans-split-18
  prefs: []
  type: TYPE_NORMAL
  zh: 镁是人体的重要矿物质，是数百种酶反应的必要辅因子。这些反应包括能量代谢、蛋白质和核酸合成以及胰岛素的分泌和作用（6, 7）。它在维持正常神经和肌肉功能、支持健康的免疫系统和确保稳定心跳方面发挥着关键作用。尽管其重要性，镁缺乏是广泛存在且常被忽视的公共卫生问题。超过一半的美国人口未能达到推荐的镁摄入量，导致镁缺乏的高估预val（∼15%）（8）。研究发现，低镁血症与糖尿病、中风和冠状动脉疾病患者的风险增加和不良预后相关。增加镁的摄入可以降低糖尿病、中风和高血压的风险（9,
    10）。
- en: Although serum magnesium is frequently used in clinical settings to assess magnesium
    deficiency (11), it may not accurately reflect the body's overall magnesium status.
    This is largely due to the kidneys’ role in absorbing more than 80% of plasma
    magnesium, a process vital for maintaining magnesium homeostasis. In light of
    this, Fan et al (12) developed the magnesium depletion score (MDS), a composite
    score that aggregates 4 established risk factors and also takes into account the
    pathophysiological factors influencing the kidneys’ reabsorption capability. A
    higher MDS indicates a more severe state of magnesium deficiency. However, to
    our knowledge, the association between the MDS and MetS has not been studied.
    It may therefore be helpful to further explore the relationship between MDS and
    MetS to develop future prevention or treatment methods for this disease. We investigated
    the association between MDS and MetS by examining 80 312 participants from the
    NHANES from 2003 to 2018.
  id: totrans-split-19
  prefs: []
  type: TYPE_NORMAL
  zh: 尽管血清镁常用于临床设置中评估镁缺乏（11），但它可能不能准确反映身体的整体镁状态。这主要是由于肾脏在吸收超过80%的血浆镁中起作用，这是维持镁稳态至关重要的过程。因此，樊等人（12）开发了镁耗竭评分（MDS），这是一个综合评分，汇总了4个已确定的风险因素，并考虑了影响肾脏重吸收能力的病理生理因素。较高的MDS表示镁缺乏状况更为严重。然而据我们所知，MDS与代谢综合征之间的关联尚未研究。因此，进一步探讨MDS与代谢综合征之间的关系可能有助于制定未来预防或治疗该疾病的方法。我们通过检查2003年至2018年NHANES的80,312名参与者，研究了MDS与代谢综合征之间的关联。
- en: Materials and Methods
  id: totrans-split-20
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 材料和方法
- en: Study Population and Design
  id: totrans-split-21
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 研究人群和设计
- en: Data for this study were obtained from the National Health and Nutrition Examination
    Survey website ([https://www.cdc.gov/nchs/nhanes/index.htm](https://www.cdc.gov/nchs/nhanes/index.htm)).
    In this study, 9 cycles of NHANES data (2003-2018) were collected by the Centers
    for Disease Control and Prevention. NHANES is a multistage, stratified, large,
    nationally representative study of the US population that provides detailed information
    about the study design, interviews, demographics, etc (13-15). Among the sample
    of 80 312 adults, those who did not provide MDS information or other variables
    were excluded (Fig. 1). Protocol approval was granted by the National Center for
    Health Statistics’ ethical review board, and informed consent forms were signed
    by participants.
  id: totrans-split-22
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究的数据来源于美国疾病控制与预防中心国家健康和营养调查网站（[https://www.cdc.gov/nchs/nhanes/index.htm](https://www.cdc.gov/nchs/nhanes/index.htm)）。在本研究中，我们收集了9个周期（2003-2018年）的NHANES数据，这些数据由美国疾病控制与预防中心进行。NHANES是美国全国代表性的多阶段、分层、大样本研究，详细信息涵盖了研究设计、访谈、人口统计学等（13-15）。在80,312名成年人的样本中，未提供MDS信息或其他变量的人员被排除在外（图
    1）。研究方案已获得国家卫生统计中心伦理审查委员会的批准，并且参与者已签署知情同意书。
- en: Figure 1.
  id: totrans-split-23
  prefs: []
  type: TYPE_NORMAL
  zh: 图 1.
- en: Flowchart of participant selection from National Health and Nutrition Examination
    Survey 2003 to 2018.
  id: totrans-split-24
  prefs: []
  type: TYPE_NORMAL
  zh: 从2003年到2018年国家健康和营养检查调查中选择参与者的流程图。
- en: Calculation of the Magnesium Depletion Score
  id: totrans-split-25
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 镁耗竭评分的计算
- en: 'The MDS was calculated to evaluate total-body magnesium status. The MDS was
    calculated as the sum of the following 4 scores: (1) current use of diuretics
    was scored 1 point; (2) current use of proton pump inhibitor (PPI) was scored
    1 point; (3) an estimated glomerular filtration rate (eGFR) between 60 mL/min/1.73 m²
    and 90 mL/min/1.73 m² was scored 1 point, while an eGFR less than 60 mL/min/1.73 m²
    was scored 2 points; and (4) heavy drinking (>1 drink/d for women and >2 drinks/d
    for men) was scored 1 point (12). The eGFR was calculated using the Chronic Kidney
    Disease Epidemiology Collaboration formula (16). According to the Food Patterns
    Equivalents Database, alcoholic drinks include all types of beers, wines, distilled
    spirits (such as brandy, gin, rum, vodka, and whiskey), cordials, and liqueurs.
    One drink was defined as the amount of alcoholic beverage containing 0.6 fluid
    ounces or 14 g of ethanol. MDS was categorized into 6 groups: MDS = 0, MDS = 1,
    MDS = 2, MDS = 3, MDS = 4, and MDS = 5.'
  id: totrans-split-26
  prefs: []
  type: TYPE_NORMAL
  zh: MDS是用来评估全身镁状态的计算值。MDS是以下4个分数的总和计算得出的：（1）当前使用利尿剂得分1分；（2）当前使用质子泵抑制剂（PPI）得分1分；（3）估计肾小球滤过率（eGFR）在60
    mL/min/1.73 m²至90 mL/min/1.73 m²之间得分1分，而eGFR低于60 mL/min/1.73 m²得分2分；以及（4）大量饮酒（女性每天>1杯，男性每天>2杯）得分1分（12）。eGFR是使用慢性肾脏病流行病学合作组方程计算的（16）。根据食物模式等价数据库，含酒精饮料包括各种啤酒、葡萄酒、烈性酒（如白兰地、杜松子酒、朗姆酒、伏特加和威士忌）、利口酒和甜酒。一杯酒的定义是含有0.6液体盎司或14克乙醇的酒精饮料。MDS分为6组：MDS
    = 0、MDS = 1、MDS = 2、MDS = 3、MDS = 4和MDS = 5。
- en: Diagnosis of Metabolic Syndrome
  id: totrans-split-27
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 代谢综合征的诊断
- en: 'MetS was defined according to the NCEP-ATP III report (5). Participants were
    diagnosed with MetS if they met at least 3 of the following 5 criteria: (1) central
    obesity: waist circumference greater than or equal to 102 cm in men, or greater
    than or equal to 88 cm in women; (2) hypertriglyceridemia: serum TGs greater than
    or equal to 150 mg/dL; (3) low HDL-c: serum HDL-c less than 40 mg/dL in men and
    less than 50 mg/dL in women; (4) hypertension: systolic blood pressure (SBP) greater
    than or equal to 130 mm Hg, or diastolic blood pressure (DBP) greater than or
    equal to 85 mm Hg, or receiving antihypertensive treatment; (5) hyperglycemia:
    fasting glucose greater than or equal to 100 mg/dL, or receiving antihyperglycemic
    treatments. Data on waist circumference, body weight, and height were collected
    using standard procedures during physical examinations. SBP and DBP were calculated
    as the arithmetic averages of repeated measures (up to 4 times) for each participant.
    TGs and HDL-c were measured in serum, while fasting glucose was measured in plasma.'
  id: totrans-split-28
  prefs: []
  type: TYPE_NORMAL
  zh: 根据NCEP-ATP III报告（5），MetS的定义如下：如果参与者符合以下5个标准中的至少3个，则被诊断为MetS：（1）中心性肥胖：男性腰围大于或等于102
    cm，女性大于或等于88 cm；（2）高三酰甘油血症：血清三酰甘油大于或等于150 mg/dL；（3）低HDL胆固醇：男性血清HDL胆固醇小于40 mg/dL，女性小于50
    mg/dL；（4）高血压：收缩压（SBP）大于或等于130 mm Hg，舒张压（DBP）大于或等于85 mm Hg，或接受抗高血压治疗；（5）高血糖：空腹血糖大于或等于100
    mg/dL，或接受抗高血糖治疗。在体格检查期间使用标准程序收集了腰围、体重和身高数据。SBP和DBP分别作为每位参与者重复测量（最多4次）的算术平均值计算。TGs和HDL胆固醇在血清中测量，而空腹血糖在血浆中测量。
- en: Covariates Assessment
  id: totrans-split-29
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 混杂变量评估
- en: NHANES collects some sociodemographic information through structured data. The
    main covariates in this study were demographic characteristics and chronic comorbidities.
    Demographic characteristics, including age, sex, race, and education level, were
    reported by interviewees. Measurements of waist size, weight, and height were
    taken by well-trained health technologists following the anthropometry procedure
    manual. Body mass index (BMI) was calculated as weight (kg) divided by height
    squared (m²). Currently used clinical criteria and guidelines issued by the International
    Diabetes Association were used to diagnose diabetes, with diabetes classified
    by either fasting blood glucose greater than or equal to 7.0 mmol/L in laboratory
    tests, blood glucose greater than 11.1 mmol/L in the oral glucose tolerance test
    experiment, those taking diabetes medications, those diagnosed with diabetes by
    their doctors during the survey, and those who self-reported. Hypertension was
    defined as a mean SBP greater than or equal to 140 mm Hg or DBP greater than or
    equal to 90 mm Hg or current use of antihypertensive medication as per self-reported
    questionnaire. Other chronic comorbidities such as hyperlipidemia were identified
    either through a doctor's diagnosis or a self-reported questionnaire.
  id: totrans-split-30
  prefs: []
  type: TYPE_NORMAL
  zh: NHANES通过结构化数据收集了一些社会人口统计学信息。本研究的主要混杂变量是人口特征和慢性共病。被访者报告了年龄、性别、种族和教育水平等人口特征。腰围、体重和身高的测量是由经过良好训练的健康技术人员按照人类测量学程序手册进行的。身体质量指数（BMI）计算公式为体重（kg）除以身高的平方（m²）。目前使用的临床标准和国际糖尿病联盟发布的指南被用于诊断糖尿病，糖尿病的分类包括实验室测试中空腹血糖大于或等于7.0
    mmol/L、口服葡萄糖耐量试验中血糖大于11.1 mmol/L、服用糖尿病药物、在调查期间由医生诊断为糖尿病以及自我报告者。高血压定义为平均收缩压大于或等于140
    mm Hg或舒张压大于或等于90 mm Hg，或根据自我报告问卷使用抗高血压药物。其他慢性共病如高脂血症通过医生的诊断或自我报告问卷确定。
- en: Statistical Analyses
  id: totrans-split-31
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 统计分析
- en: 'For all individuals in the present study, descriptive analyses were performed
    on the characteristics of each participant. Statistical analysis was conducted
    using R open-source software version 4.3.1 to analyze the data for this study.
    Data extraction and analyses were performed with the use of the “nhanesR” package
    of R software(R Core Team; 2023\. R: A Language and Environment for Statistical
    Computing. R Foundation for Statistical Computing, [https://www.R-project.org/](https://www.R-project.org/)).
    For continuous variables, the mean and SD were reported, while for categorical
    variables, percentages were reported. For continuous variables, the baseline characteristics
    were analyzed using a linear regression model, and for categorical variables,
    they were analyzed using a chi-square test. Weighted univariate and multivariable
    logistic regression were used to assess the association between MDS and MetS.
    The formulas for multivariable logistic regression were: log(p/(1 − p)) = β0 +
    β1X1 + β2X2 + … + βnXn (where p = probability of MetS, β0 = intercept, β1 to βn
    = regression coefficients for each predictor variable, X1 to Xn = predictor variables
    (age, sex, race, etc). Four models were created: a crude model with no adjustments
    for confounding factors; model 1, adjusted for age, sex, race, and education level;
    model 2, adjusted for the variables in model 1 plus BMI, waist, alanine transaminase
    (ALT), aspartate transaminase (AST), TGs, total cholesterol (TC), HDL-c, low-density
    lipoprotein cholesterol (LDL-c), homeostatic model assessment for insulin resistance
    (HOMA-IR), glycated hemoglobin A[1c] (HbA[1c]), corrected calcium (Ca), smoking,
    and drinking; and model 3, adjusted for the variables in model 2 plus hyperlipidemia,
    diabetes, and hypertension. Restricted cubic spline (RCS) analysis was conducted
    to characterize dose-response relationships. Stratified analyses by sociodemographic
    and lifestyle factors were also performed. We considered all survey sampling weights
    when analyzing the data, which were considered statistically significant if *P*
    was less than .05.'
  id: totrans-split-32
  prefs: []
  type: TYPE_NORMAL
  zh: 对于本研究中的所有个体，对每位参与者的特征进行了描述性分析。使用开源软件 R 版本 4.3.1 进行了统计分析，以分析本研究的数据。使用 R 软件的 "nhanesR"
    包进行了数据提取和分析（R核心团队; 2023. R:统计计算的语言与环境。R基金会为统计计算，[https://www.R-project.org/](https://www.R-project.org/)）。对于连续变量，报告了平均值和标准差，而对于分类变量，则报告了百分比。对于连续变量，使用线性回归模型分析了基线特征，对于分类变量，则使用了卡方检验进行了分析。采用加权单变量和多变量
    logistic 回归评估了 MDS 与 MetS 之间的关联。多变量 logistic 回归的公式为：log(p/(1 − p)) = β0 + β1X1
    + β2X2 + … + βnXn（其中 p = MetS 的概率，β0 = 截距，β1 到 βn = 每个预测变量的回归系数，X1 到 Xn = 预测变量（年龄、性别、种族等）。创建了四个模型：一个未调整混杂因素的粗略模型；模型
    1，调整了年龄、性别、种族和教育水平；模型 2，调整了模型 1 中的变量加上 BMI、腰围、丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）、三酰甘油（TGs）、总胆固醇（TC）、高密度脂蛋白胆固醇（HDL-c）、低密度脂蛋白胆固醇（LDL-c）、胰岛素抵抗的稳态模型评估（HOMA-IR）、糖化血红蛋白A[1c]（HbA[1c]）、校正钙（Ca）、吸烟和饮酒；以及模型
    3，调整了模型 2 中的变量加上高脂血症、糖尿病和高血压。进行了限制性立方样条（RCS）分析以表征剂量-反应关系。还进行了社会人口学和生活方式因素的分层分析。在分析数据时考虑了所有调查抽样权重，如果
    *P* 小于 .05 则被认为具有统计学意义。
- en: Results
  id: totrans-split-33
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 结果
- en: Baseline Characteristics of Study Participants by Metabolic Syndrome
  id: totrans-split-34
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 代谢综合征患者的基线特征
- en: Between 2003 and 2018, a total of 80 312 participants were involved in NHANES
    (see Fig. 1). Participants who did not provide relevant information for the calculation
    of MetS, MDS, or other variables were excluded, resulting in a final sample of
    15 565 participants for statistical analysis. Of these, 10 127 did not have MetS,
    while 5438 did. In Table 1, we show the general characteristics of the study population
    based on whether they had MetS. Compared to individuals without MetS, those with
    MetS were found to be more likely older, of non-Hispanic white ethnicity, smokers,
    nondrinkers, and with a lower education level. They also exhibited higher BMI,
    waist circumference, ALT, AST, TGs, TC, LDL-c, and MDS, but lower eGFR. Furthermore,
    individuals with MetS demonstrated more severe insulin resistance, higher levels
    of HbA[1c], and were more likely to have a history of hyperlipidemia, hypertension,
    and diabetes. MDS was categorized into 6 levels from 0 to 5\. The proportion of
    participants with MDS = 0 was lower in the MetS group compared to the non-MetS
    group (32.48% vs 49.41%), while the proportions for MDS greater than or equal
    to 2 were all higher in the MetS group (all *P* < .05).
  id: totrans-split-35
  prefs: []
  type: TYPE_NORMAL
  zh: 从2003年到2018年，共有80,312名参与者参与了NHANES（见图1）。未提供用于计算MetS、MDS或其他变量的相关信息的参与者被排除在外，最终纳入统计分析的参与者为15,565名。其中，10,127名没有代谢综合征，而5,438名有。在表1中，我们展示了研究人群的一般特征，根据是否患有代谢综合征进行分类。与没有代谢综合征的个体相比，患有代谢综合征的个体更可能年龄较大，属于非西班牙裔白种人种群，吸烟者，不喝酒，并且具有较低的教育水平。他们还表现出较高的BMI，腰围，ALT，AST，TGs，TC，LDL-c和MDS，但eGFR较低。此外，患有代谢综合征的个体表现出更严重的胰岛素抵抗，较高水平的HbA[1c]，并且更有可能患有高脂血症，高血压和糖尿病的病史。MDS被分类为从0到5的6个级别。与无代谢综合征组相比，MDS
    = 0的参与者比例在代谢综合征组中较低（32.48% vs 49.41%），而MDS大于或等于2的比例在代谢综合征组中都较高（所有*P* < .05）。
- en: Table 1.
  id: totrans-split-36
  prefs: []
  type: TYPE_NORMAL
  zh: 表1。
- en: Baseline characteristics of participants with or without metabolic syndrome
  id: totrans-split-37
  prefs: []
  type: TYPE_NORMAL
  zh: 参与者基线特征，具有或不具有代谢综合征
- en: '| Characters . | Total . | Non–metabolic syndrome . | Metabolic syndrome .
    | *P* . |'
  id: totrans-split-38
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | 总计 . | 非代谢综合征 . | 代谢综合征 . | *P* . |'
- en: '| --- | --- | --- | --- | --- |'
  id: totrans-split-39
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- |'
- en: '| Age, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
  id: totrans-split-40
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
- en: '| Sex |  |  |  | .06 |'
  id: totrans-split-41
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  |  | .06 |'
- en: '|  Male | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
  id: totrans-split-42
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
- en: '|  Female | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
  id: totrans-split-43
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
- en: '| Race |  |  |  | **<.0001** |'
  id: totrans-split-44
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  |  | **<.0001** |'
- en: '|  Non-Hispanic White | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
  id: totrans-split-45
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
- en: '|  Non-Hispanic Black | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
  id: totrans-split-46
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
- en: '|  Mexican American | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
  id: totrans-split-47
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥美国人 | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
- en: '|  Other race | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
  id: totrans-split-48
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
- en: '| Education |  |  |  | **<.0001** |'
  id: totrans-split-49
  prefs: []
  type: TYPE_TB
  zh: '| 教育 |  |  |  | **<.0001** |'
- en: '|  > High school | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
  id: totrans-split-50
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
- en: '|  High school | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
  id: totrans-split-51
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
- en: '|  < High school | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
  id: totrans-split-52
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
- en: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
  id: totrans-split-53
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
- en: '| Waist, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
  id: totrans-split-54
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
- en: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
  id: totrans-split-55
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
- en: '| MDS |  |  |  | **<.0001** |'
  id: totrans-split-56
  prefs: []
  type: TYPE_TB
  zh: '| MDS |  |  |  | **<.0001** |'
- en: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
  id: totrans-split-57
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
- en: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
  id: totrans-split-58
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
- en: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
  id: totrans-split-59
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
- en: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
  id: totrans-split-60
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
- en: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
  id: totrans-split-61
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
- en: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
  id: totrans-split-62
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
- en: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
  id: totrans-split-63
  prefs: []
  type: TYPE_TB
  zh: '| ALT，U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
- en: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
  id: totrans-split-64
  prefs: []
  type: TYPE_TB
  zh: '| AST，U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
- en: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
  id: totrans-split-65
  prefs: []
  type: TYPE_TB
  zh: '| TGs，mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
- en: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
  id: totrans-split-66
  prefs: []
  type: TYPE_TB
  zh: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
- en: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
  id: totrans-split-67
  prefs: []
  type: TYPE_TB
  zh: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
- en: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
  id: totrans-split-68
  prefs: []
  type: TYPE_TB
  zh: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
- en: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
  id: totrans-split-69
  prefs: []
  type: TYPE_TB
  zh: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
- en: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
  id: totrans-split-70
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
- en: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
  id: totrans-split-71
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
- en: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
  id: totrans-split-72
  prefs: []
  type: TYPE_TB
  zh: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
- en: '| Smoking |  |  |  | **<.0001** |'
  id: totrans-split-73
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  |  | **<.0001** |'
- en: '|  No | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
  id: totrans-split-74
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
- en: '|  Yes | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
  id: totrans-split-75
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
- en: '| Drinking |  |  |  | **<.001** |'
  id: totrans-split-76
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  |  | **<.001** |'
- en: '|  No | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
  id: totrans-split-77
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
- en: '|  Yes | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
  id: totrans-split-78
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
- en: '| Hyperlipidemia |  |  |  | **<.0001** |'
  id: totrans-split-79
  prefs: []
  type: TYPE_TB
  zh: '| 高血脂症 |  |  |  | **<.0001** |'
- en: '|  No | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
  id: totrans-split-80
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
- en: '|  Yes | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
  id: totrans-split-81
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
- en: '| Hypertension |  |  |  | **<.0001** |'
  id: totrans-split-82
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |  |  |  | **<.0001** |'
- en: '|  No | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
  id: totrans-split-83
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
- en: '|  Yes | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
  id: totrans-split-84
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
- en: '| Diabetes |  |  |  | **<.0001** |'
  id: totrans-split-85
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |  |  |  | **<.0001** |'
- en: '|  No | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
  id: totrans-split-86
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
- en: '|  Yes | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
  id: totrans-split-87
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
- en: '| Characters . | Total . | Non–metabolic syndrome . | Metabolic syndrome .
    | *P* . |'
  id: totrans-split-88
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | 总 . | 非代谢综合征 . | 代谢综合征 . | *P* . |'
- en: '| --- | --- | --- | --- | --- |'
  id: totrans-split-89
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- |'
- en: '| Age, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
  id: totrans-split-90
  prefs: []
  type: TYPE_TB
  zh: '| 年龄, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
- en: '| Sex |  |  |  | .06 |'
  id: totrans-split-91
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  |  | .06 |'
- en: '|  Male | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
  id: totrans-split-92
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
- en: '|  Female | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
  id: totrans-split-93
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
- en: '| Race |  |  |  | **<.0001** |'
  id: totrans-split-94
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  |  | **<.0001** |'
- en: '|  Non-Hispanic White | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
  id: totrans-split-95
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
- en: '|  Non-Hispanic Black | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
  id: totrans-split-96
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
- en: '|  Mexican American | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
  id: totrans-split-97
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
- en: '|  Other race | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
  id: totrans-split-98
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
- en: '| Education |  |  |  | **<.0001** |'
  id: totrans-split-99
  prefs: []
  type: TYPE_TB
  zh: '| 受教育程度 |  |  |  | **<.0001** |'
- en: '|  > High school | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
  id: totrans-split-100
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
- en: '|  High school | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
  id: totrans-split-101
  prefs: []
  type: TYPE_TB
  zh: '|  高中毕业 | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
- en: '|  < High school | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
  id: totrans-split-102
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
- en: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
  id: totrans-split-103
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
- en: '| Waist, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
  id: totrans-split-104
  prefs: []
  type: TYPE_TB
  zh: '| 腰围, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
- en: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
  id: totrans-split-105
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
- en: '| MDS |  |  |  | **<.0001** |'
  id: totrans-split-106
  prefs: []
  type: TYPE_TB
  zh: '| MDS |  |  |  | **<.0001** |'
- en: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
  id: totrans-split-107
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
- en: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
  id: totrans-split-108
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
- en: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
  id: totrans-split-109
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
- en: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
  id: totrans-split-110
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
- en: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
  id: totrans-split-111
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
- en: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
  id: totrans-split-112
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
- en: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
  id: totrans-split-113
  prefs: []
  type: TYPE_TB
  zh: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
- en: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
  id: totrans-split-114
  prefs: []
  type: TYPE_TB
  zh: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
- en: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
  id: totrans-split-115
  prefs: []
  type: TYPE_TB
  zh: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
- en: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
  id: totrans-split-116
  prefs: []
  type: TYPE_TB
  zh: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
- en: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
  id: totrans-split-117
  prefs: []
  type: TYPE_TB
  zh: '| HDL-c，mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
- en: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
  id: totrans-split-118
  prefs: []
  type: TYPE_TB
  zh: '| LDL-c，mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
- en: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
  id: totrans-split-119
  prefs: []
  type: TYPE_TB
  zh: '| eGFR，mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
- en: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
  id: totrans-split-120
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
- en: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
  id: totrans-split-121
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c]，% | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
- en: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
  id: totrans-split-122
  prefs: []
  type: TYPE_TB
  zh: '| 钙，mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
- en: '| Smoking |  |  |  | **<.0001** |'
  id: totrans-split-123
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  |  | **<.0001** |'
- en: '|  No | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
  id: totrans-split-124
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 8524（54.21%） | 5780（56.56%） | 2744（49.36%） |  |'
- en: '|  Yes | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
  id: totrans-split-125
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 7043（45.79%） | 4349（43.44%） | 2694（50.64%） |  |'
- en: '| Drinking |  |  |  | **<.001** |'
  id: totrans-split-126
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  |  | **<.001** |'
- en: '|  No | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
  id: totrans-split-127
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 2188（10.92%） | 1331（10.27%） | 857（12.27%） |  |'
- en: '|  Yes | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
  id: totrans-split-128
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 13 379（89.08%） | 8798（89.73%） | 4581（87.73%） |  |'
- en: '| Hyperlipidemia |  |  |  | **<.0001** |'
  id: totrans-split-129
  prefs: []
  type: TYPE_TB
  zh: '| 高血脂症 |  |  |  | **<.0001** |'
- en: '|  No | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
  id: totrans-split-130
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 4454（29.54%） | 4076（40.54%） | 378（6.78%） |  |'
- en: '|  Yes | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
  id: totrans-split-131
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 11 113（70.46%） | 6053（59.46%） | 5060（93.22%） |  |'
- en: '| Hypertension |  |  |  | **<.0001** |'
  id: totrans-split-132
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |  |  |  | **<.0001** |'
- en: '|  No | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
  id: totrans-split-133
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 9062（62.69%） | 7357（76.53%） | 1705（34.06%） |  |'
- en: '|  Yes | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
  id: totrans-split-134
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6505（37.31%） | 2772（23.47%） | 3733（65.94%） |  |'
- en: '| Diabetes |  |  |  | **<.0001** |'
  id: totrans-split-135
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |  |  |  | **<.0001** |'
- en: '|  No | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
  id: totrans-split-136
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 12 534（85.20%） | 9364（94.97%） | 3170（64.97%） |  |'
- en: '|  Yes | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
  id: totrans-split-137
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 3033（14.80%） | 765（5.03%） | 2268（35.03%） |  |'
- en: Table 1.
  id: totrans-split-138
  prefs: []
  type: TYPE_NORMAL
  zh: 表1。
- en: Baseline characteristics of participants with or without metabolic syndrome
  id: totrans-split-139
  prefs: []
  type: TYPE_NORMAL
  zh: 参与者基线特征（是否有代谢综合征）
- en: '| Characters . | Total . | Non–metabolic syndrome . | Metabolic syndrome .
    | *P* . |'
  id: totrans-split-140
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | 总 . | 非代谢综合征 . | 代谢综合征 . | *P* . |'
- en: '| --- | --- | --- | --- | --- |'
  id: totrans-split-141
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- |'
- en: '| Age, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
  id: totrans-split-142
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
- en: '| Sex |  |  |  | .06 |'
  id: totrans-split-143
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  |  | .06 |'
- en: '|  Male | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
  id: totrans-split-144
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 7823（49.78%） | 5278（50.54%） | 2545（48.20%） |  |'
- en: '|  Female | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
  id: totrans-split-145
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 7744（50.22%） | 4851（49.46%） | 2893（51.80%） |  |'
- en: '| Race |  |  |  | **<.0001** |'
  id: totrans-split-146
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  |  | **<.0001** |'
- en: '|  Non-Hispanic White | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
  id: totrans-split-147
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 7029（69.83%） | 4411（68.37%） | 2618（72.85%） |  |'
- en: '|  Non-Hispanic Black | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
  id: totrans-split-148
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 3115（10.15%） | 2108（10.66%） | 1007（9.09%） |  |'
- en: '|  Mexican American | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
  id: totrans-split-149
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 2544（8.24%） | 1613（8.35%） | 931（8.03%） |  |'
- en: '|  Other race | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
  id: totrans-split-150
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 2879（11.78%） | 1997（12.62%） | 882（10.03%） |  |'
- en: '| Education |  |  |  | **<.0001** |'
  id: totrans-split-151
  prefs: []
  type: TYPE_TB
  zh: '| 教育 |  |  |  | **<.0001** |'
- en: '|  > High school | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
  id: totrans-split-152
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 8029（59.90%） | 5539（62.99%） | 2490（53.50%） |  |'
- en: '|  High school | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
  id: totrans-split-153
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 5955（34.89%） | 3704（32.42%） | 2251（39.99%） |  |'
- en: '|  < High school | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
  id: totrans-split-154
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1583（5.21%） | 886（4.59%） | 697（6.51%） |  |'
- en: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
  id: totrans-split-155
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
- en: '| Waist, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
  id: totrans-split-156
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，厘米 | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
- en: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
  id: totrans-split-157
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
- en: '| MDS |  |  |  | **<.0001** |'
  id: totrans-split-158
  prefs: []
  type: TYPE_TB
  zh: '| MDS |  |  |  | **<.0001** |'
- en: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
  id: totrans-split-159
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 7135（44.23%） | 5366（49.91%） | 1769（32.48%） |  |'
- en: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
  id: totrans-split-160
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 5057（35.79%） | 3352（36.76%） | 1705（33.78%） |  |'
- en: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
  id: totrans-split-161
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 2292（14.23%） | 1087（10.65%） | 1205（21.65%） |  |'
- en: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
  id: totrans-split-162
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 885（4.67%） | 276（2.25%） | 609（9.66%） |  |'
- en: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
  id: totrans-split-163
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 192（1.05%） | 45（0.41%） | 147（2.39%） |  |'
- en: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
  id: totrans-split-164
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 6（0.03%） | 3（0.02%） | 3（0.03%） |  |'
- en: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
  id: totrans-split-165
  prefs: []
  type: TYPE_TB
  zh: '| ALT，U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
- en: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
  id: totrans-split-166
  prefs: []
  type: TYPE_TB
  zh: '| AST，U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
- en: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
  id: totrans-split-167
  prefs: []
  type: TYPE_TB
  zh: '| TGs，mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
- en: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
  id: totrans-split-168
  prefs: []
  type: TYPE_TB
  zh: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
- en: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
  id: totrans-split-169
  prefs: []
  type: TYPE_TB
  zh: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
- en: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
  id: totrans-split-170
  prefs: []
  type: TYPE_TB
  zh: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
- en: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
  id: totrans-split-171
  prefs: []
  type: TYPE_TB
  zh: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
- en: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
  id: totrans-split-172
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
- en: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
  id: totrans-split-173
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
- en: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
  id: totrans-split-174
  prefs: []
  type: TYPE_TB
  zh: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
- en: '| Smoking |  |  |  | **<.0001** |'
  id: totrans-split-175
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  |  | **<.0001** |'
- en: '|  No | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
  id: totrans-split-176
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
- en: '|  Yes | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
  id: totrans-split-177
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
- en: '| Drinking |  |  |  | **<.001** |'
  id: totrans-split-178
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  |  | **<.001** |'
- en: '|  No | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
  id: totrans-split-179
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
- en: '|  Yes | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
  id: totrans-split-180
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
- en: '| Hyperlipidemia |  |  |  | **<.0001** |'
  id: totrans-split-181
  prefs: []
  type: TYPE_TB
  zh: '| 高脂血症 |  |  |  | **<.0001** |'
- en: '|  No | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
  id: totrans-split-182
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
- en: '|  Yes | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
  id: totrans-split-183
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
- en: '| Hypertension |  |  |  | **<.0001** |'
  id: totrans-split-184
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |  |  |  | **<.0001** |'
- en: '|  No | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
  id: totrans-split-185
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
- en: '|  Yes | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
  id: totrans-split-186
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
- en: '| Diabetes |  |  |  | **<.0001** |'
  id: totrans-split-187
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |  |  |  | **<.0001** |'
- en: '|  No | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
  id: totrans-split-188
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
- en: '|  Yes | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
  id: totrans-split-189
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
- en: '| Characters . | Total . | Non–metabolic syndrome . | Metabolic syndrome .
    | *P* . |'
  id: totrans-split-190
  prefs: []
  type: TYPE_TB
  zh: '| 字符数 . | 总计 . | 非代谢综合征 . | 代谢综合征 . | *P* . |'
- en: '| --- | --- | --- | --- | --- |'
  id: totrans-split-191
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- |'
- en: '| Age, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
  id: totrans-split-192
  prefs: []
  type: TYPE_TB
  zh: '| 年龄, y | 47.3 ± 0.3 | 43.7 ± 0.3 | 54.7 ± 0.3 | **<.0001** |'
- en: '| Sex |  |  |  | .06 |'
  id: totrans-split-193
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  |  | .06 |'
- en: '|  Male | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
  id: totrans-split-194
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 7823 (49.78%) | 5278 (50.54%) | 2545 (48.20%) |  |'
- en: '|  Female | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
  id: totrans-split-195
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 7744 (50.22%) | 4851 (49.46%) | 2893 (51.80%) |  |'
- en: '| Race |  |  |  | **<.0001** |'
  id: totrans-split-196
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  |  | **<.0001** |'
- en: '|  Non-Hispanic White | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
  id: totrans-split-197
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 7029 (69.83%) | 4411 (68.37%) | 2618 (72.85%) |  |'
- en: '|  Non-Hispanic Black | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
  id: totrans-split-198
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 3115 (10.15%) | 2108 (10.66%) | 1007 (9.09%) |  |'
- en: '|  Mexican American | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
  id: totrans-split-199
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 2544 (8.24%) | 1613 (8.35%) | 931 (8.03%) |  |'
- en: '|  Other race | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
  id: totrans-split-200
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 2879 (11.78%) | 1997 (12.62%) | 882 (10.03%) |  |'
- en: '| Education |  |  |  | **<.0001** |'
  id: totrans-split-201
  prefs: []
  type: TYPE_TB
  zh: '| 教育 |  |  |  | **<.0001** |'
- en: '|  > High school | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
  id: totrans-split-202
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 8029 (59.90%) | 5539 (62.99%) | 2490 (53.50%) |  |'
- en: '|  High school | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
  id: totrans-split-203
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 5955 (34.89%) | 3704 (32.42%) | 2251 (39.99%) |  |'
- en: '|  < High school | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
  id: totrans-split-204
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1583 (5.21%) | 886 (4.59%) | 697 (6.51%) |  |'
- en: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
  id: totrans-split-205
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 28.83 ± 0.09 | 26.70 ± 0.09 | 33.25 ± 0.15 | **<.0001** |'
- en: '| Waist, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
  id: totrans-split-206
  prefs: []
  type: TYPE_TB
  zh: '| 腰围, cm | 98.88 ± 0.23 | 92.94 ± 0.21 | 111.18 ± 0.33 | **<.0001** |'
- en: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
  id: totrans-split-207
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 0.83 ± 0.01 | 0.67 ± 0.01 | 1.16 ± 0.02 | **<.0001** |'
- en: '| MDS |  |  |  | **<.0001** |'
  id: totrans-split-208
  prefs: []
  type: TYPE_TB
  zh: '| MDS |  |  |  | **<.0001** |'
- en: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
  id: totrans-split-209
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 7135 (44.23%) | 5366 (49.91%) | 1769 (32.48%) |  |'
- en: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
  id: totrans-split-210
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 5057 (35.79%) | 3352 (36.76%) | 1705 (33.78%) |  |'
- en: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
  id: totrans-split-211
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 2292 (14.23%) | 1087 (10.65%) | 1205 (21.65%) |  |'
- en: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
  id: totrans-split-212
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 885 (4.67%) | 276 (2.25%) | 609 (9.66%) |  |'
- en: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
  id: totrans-split-213
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 192 (1.05%) | 45 (0.41%) | 147 (2.39%) |  |'
- en: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
  id: totrans-split-214
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 6 (0.03%) | 3 (0.02%) | 3 (0.03%) |  |'
- en: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
  id: totrans-split-215
  prefs: []
  type: TYPE_TB
  zh: '| ALT, U/L | 25.27 ± 0.17 | 23.77 ± 0.18 | 28.37 ± 0.34 | **<.0001** |'
- en: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
  id: totrans-split-216
  prefs: []
  type: TYPE_TB
  zh: '| AST, U/L | 25.07 ± 0.16 | 24.60 ± 0.16 | 26.04 ± 0.29 | **<.0001** |'
- en: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
  id: totrans-split-217
  prefs: []
  type: TYPE_TB
  zh: '| TGs, mmol/L | 1.35 ± 0.01 | 1.09 ± 0.01 | 1.90 ± 0.02 | **<.0001** |'
- en: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
  id: totrans-split-218
  prefs: []
  type: TYPE_TB
  zh: '| TC, mmol/L | 5.01 ± 0.01 | 4.99 ± 0.01 | 5.06 ± 0.02 | **.002** |'
- en: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
  id: totrans-split-219
  prefs: []
  type: TYPE_TB
  zh: '| HDL-c, mmol/L | 1.41 ± 0.01 | 1.51 ± 0.01 | 1.21 ± 0.01 | **<.0001** |'
- en: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
  id: totrans-split-220
  prefs: []
  type: TYPE_TB
  zh: '| LDL-c, mmol/L | 2.96 ± 0.01 | 2.94 ± 0.01 | 2.99 ± 0.02 | **.02** |'
- en: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
  id: totrans-split-221
  prefs: []
  type: TYPE_TB
  zh: '| eGFR, mL/min/1.73 m² | 94.86 ± 0.34 | 98.22 ± 0.36 | 87.90 ± 0.48 | **<.0001**
    |'
- en: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
  id: totrans-split-222
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 3.45 ± 0.05 | 2.25 ± 0.03 | 5.95 ± 0.12 | **<.0001** |'
- en: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
  id: totrans-split-223
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c], % | 5.58 ± 0.01 | 5.37 ± 0.01 | 6.02 ± 0.02 | **<.0001** |'
- en: '| Ca, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
  id: totrans-split-224
  prefs: []
  type: TYPE_TB
  zh: '| 钙, mg/dL | 9.14 ± 0.01 | 9.11 ± 0.01 | 9.20 ± 0.01 | **<.0001** |'
- en: '| Smoking |  |  |  | **<.0001** |'
  id: totrans-split-225
  prefs: []
  type: TYPE_TB
  zh: 吸烟 |  |  |  | **<.0001** |
- en: '|  No | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
  id: totrans-split-226
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 8524 (54.21%) | 5780 (56.56%) | 2744 (49.36%) |  |'
- en: '|  Yes | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
  id: totrans-split-227
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 7043 (45.79%) | 4349 (43.44%) | 2694 (50.64%) |  |'
- en: '| Drinking |  |  |  | **<.001** |'
  id: totrans-split-228
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  |  | **<.001** |'
- en: '|  No | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
  id: totrans-split-229
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 2188 (10.92%) | 1331 (10.27%) | 857 (12.27%) |  |'
- en: '|  Yes | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
  id: totrans-split-230
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 13 379 (89.08%) | 8798 (89.73%) | 4581 (87.73%) |  |'
- en: '| Hyperlipidemia |  |  |  | **<.0001** |'
  id: totrans-split-231
  prefs: []
  type: TYPE_TB
  zh: 高血脂 |  |  |  | **<.0001** |
- en: '|  No | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
  id: totrans-split-232
  prefs: []
  type: TYPE_TB
  zh: '|  No | 4454 (29.54%) | 4076 (40.54%) | 378 (6.78%) |  |'
- en: '|  Yes | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
  id: totrans-split-233
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 11 113 (70.46%) | 6053 (59.46%) | 5060 (93.22%) |  |'
- en: '| Hypertension |  |  |  | **<.0001** |'
  id: totrans-split-234
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |  |  |  | **<.0001** |'
- en: '|  No | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
  id: totrans-split-235
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 9062 (62.69%) | 7357 (76.53%) | 1705 (34.06%) |  |'
- en: '|  Yes | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
  id: totrans-split-236
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6505 (37.31%) | 2772 (23.47%) | 3733 (65.94%) |  |'
- en: '| Diabetes |  |  |  | **<.0001** |'
  id: totrans-split-237
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |  |  |  | **<.0001** |'
- en: '|  No | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
  id: totrans-split-238
  prefs: []
  type: TYPE_TB
  zh: '|  No | 12 534 (85.20%) | 9364 (94.97%) | 3170 (64.97%) |  |'
- en: '|  Yes | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
  id: totrans-split-239
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 3033 (14.80%) | 765( 5.03%) | 2268 (35.03%) |  |'
- en: Univariate Logistic Regression for Factors Associated With Metabolic Syndrome
  id: totrans-split-240
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 与代谢综合征相关因素的单变量逻辑回归
- en: In Table 2, we show the results of univariate logistic regression analysis assessing
    the association between various factors and MetS. The MDS was found to be significantly
    associated with increased odds of MetS. The odds ratio (OR) for MDS was 1.78 (95%
    CI, 1.69-1.88), indicating that every 1-unit increase in MDS was associated with
    78% higher odds of having MetS. When MDS was categorized into 6 levels, there
    was a stepwise increase in the odds of MetS with increasing MDS. Using MDS = 0
    as reference, the OR (95% CI) was 1.41 (1.28-1.56) for MDS = 1; 3.12 (2.71-3.59)
    for MDS = 2; 6.59 (5.28-8.24) for MDS = 3; and 9.05 (5.97-13.73) for MDS = 4\.
    The association was statistically significant for MDS levels ranging from 1 to
    4 (all *P* < .0001). Other factors significantly associated with higher odds of
    MetS included older age, non-Hispanic White race, lower education level, higher
    BMI, larger waist circumference, elevated levels of ALT, AST, TGs, TC, LDL-c,
    HOMA-IR, HbA[1c], smoking, no alcohol drinking, and the presence of hyperlipidemia,
    hypertension, and diabetes (all *P* < .05).
  id: totrans-split-241
  prefs: []
  type: TYPE_NORMAL
  zh: 在表 2 中，我们展示了单变量 logistic 回归分析的结果，评估了各种因素与 MetS 之间的关联。发现 MDS 与 MetS 的概率显著相关。MDS
    的 OR 为 1.78 (95% CI, 1.69-1.88)，表明每增加 1 个单位的 MDS 与患 MetS 的几率增加了 78%。当 MDS 分为 6
    个水平时，随着 MDS 的增加，患 MetS 的几率逐步增加。以 MDS = 0 为参考，MDS = 1 的 OR (95% CI) 为 1.41 (1.28-1.56)；MDS
    = 2 的 OR 为 3.12 (2.71-3.59)；MDS = 3 的 OR 为 6.59 (5.28-8.24)；MDS = 4 的 OR 为 9.05
    (5.97-13.73)。对于 MDS 为 1 到 4 的水平，相关性均显著 (*P* < .0001)。其他显著与 MetS 高几率相关的因素包括年龄较大、非西班牙裔白人种族、较低教育水平、较高的
    BMI、较大的腰围、ALT、AST、TG、TC、LDL-c、HOMA-IR、HbA[1c]、吸烟、不饮酒、以及高血脂、高血压和糖尿病的存在 (所有 *P*
    < .05)。
- en: Table 2.
  id: totrans-split-242
  prefs: []
  type: TYPE_NORMAL
  zh: 表 2.
- en: Univariate logistics regression analysis of the association between magnesium
    depletion score and metabolic syndrome
  id: totrans-split-243
  prefs: []
  type: TYPE_NORMAL
  zh: 单变量逻辑回归分析镁消耗评分与代谢综合征之间的关联
- en: '| Character . | OR (95% CI) . | *P* . |'
  id: totrans-split-244
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . |'
- en: '| --- | --- | --- |'
  id: totrans-split-245
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- |'
- en: '| Age, y | 1.04 (1.04-1.04) | **<.0001** |'
  id: totrans-split-246
  prefs: []
  type: TYPE_TB
  zh: '| 年龄, y | 1.04 (1.04-1.04) | **<.0001** |'
- en: '| Sex |'
  id: totrans-split-247
  prefs: []
  type: TYPE_TB
  zh: 性别 |
- en: '|  Male | Reference | Reference |'
  id: totrans-split-248
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 参考 | 参考 |'
- en: '|  Female | 1.10 (1.00-1.21) | .06 |'
  id: totrans-split-249
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.10 (1.00-1.21) | .06 |'
- en: '| Race |'
  id: totrans-split-250
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |'
- en: '|  Non-Hispanic White | Reference | Reference |'
  id: totrans-split-251
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 参考 | 参考 |'
- en: '|  Non-Hispanic Black | 0.80 (0.72-0.89) | **<.0001** |'
  id: totrans-split-252
  prefs: []
  type: TYPE_TB
  zh: '|  非裔美国人 | 0.80 (0.72-0.89) | **<.0001** |'
- en: '|  Mexican American | 0.90 (0.79-1.03) | .12 |'
  id: totrans-split-253
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥美国人 | 0.90 (0.79-1.03) | .12 |'
- en: '|  Other Race | 0.75 (0.65-0.85) | **<.0001** |'
  id: totrans-split-254
  prefs: []
  type: TYPE_TB
  zh:  其他种族 | 0.75 (0.65-0.85) | **<.0001** |
- en: '| Education |'
  id: totrans-split-255
  prefs: []
  type: TYPE_TB
  zh: '| 教育 |'
- en: '|  > High school | Reference | Reference |'
  id: totrans-split-256
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 参考 | 参考 |'
- en: '|  High school | 1.45 (1.30-1.62) | **<.0001** |'
  id: totrans-split-257
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 1.45 (1.30-1.62) | **<.0001** |'
- en: '|  < High school | 1.67 (1.42-1.97) | **<.0001** |'
  id: totrans-split-258
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1.67 (1.42-1.97) | **<.0001** |'
- en: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
  id: totrans-split-259
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
- en: '| Waist, cm | 1.09 (1.09-1.10) | **<.0001** |'
  id: totrans-split-260
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，cm | 1.09 (1.09-1.10) | **<.0001** |'
- en: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
  id: totrans-split-261
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
- en: '|  0 | Reference | Reference |'
  id: totrans-split-262
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 参考 | 参考 |'
- en: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
  id: totrans-split-263
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
- en: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
  id: totrans-split-264
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
- en: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
  id: totrans-split-265
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
- en: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
  id: totrans-split-266
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
- en: '|  5 | 1.76 (0.32-9.56) | .51 |'
  id: totrans-split-267
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 1.76 (0.32-9.56) | .51 |'
- en: '| ALT, U/L | 1.02 (1.01-1.02) | **<.0001** |'
  id: totrans-split-268
  prefs: []
  type: TYPE_TB
  zh: '| ALT，U/L | 1.02 (1.01-1.02) | **<.0001** |'
- en: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
  id: totrans-split-269
  prefs: []
  type: TYPE_TB
  zh: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
- en: '| TGs, mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
  id: totrans-split-270
  prefs: []
  type: TYPE_TB
  zh: '| 三酰甘油，mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
- en: '| TC, mmol/L | 1.07 (1.02-1.12) | **.002** |'
  id: totrans-split-271
  prefs: []
  type: TYPE_TB
  zh: '| 总胆固醇，mmol/L | 1.07 (1.02-1.12) | **.002** |'
- en: '| HDL-c, mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
  id: totrans-split-272
  prefs: []
  type: TYPE_TB
  zh: '| 高密度脂蛋白胆固醇，mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
- en: '| LDL-c, mmol/L | 1.06 (1.01-1.11) | **.02** |'
  id: totrans-split-273
  prefs: []
  type: TYPE_TB
  zh: '| 低密度脂蛋白胆固醇，mmol/L | 1.06 (1.01-1.11) | **.02** |'
- en: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
  id: totrans-split-274
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
- en: '| HbA[1c], % | 3.82 (3.34-4.37) | **<.0001** |'
  id: totrans-split-275
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c]，% | 3.82 (3.34-4.37) | **<.0001** |'
- en: '| Ca, mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
  id: totrans-split-276
  prefs: []
  type: TYPE_TB
  zh: '| 钙，mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
- en: '| Smoking |'
  id: totrans-split-277
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-278
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 1.34 (1.23-1.45) | **<.0001** |'
  id: totrans-split-279
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.34 (1.23-1.45) | **<.0001** |'
- en: '| Drinking |'
  id: totrans-split-280
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-281
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 0.82 (0.73-0.92) | **<.001** |'
  id: totrans-split-282
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 0.82 (0.73-0.92) | **<.001** |'
- en: '| Hyperlipidemia |'
  id: totrans-split-283
  prefs: []
  type: TYPE_TB
  zh: '| 高血脂 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-284
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 9.37 (7.80-11.26) | **<.0001** |'
  id: totrans-split-285
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 9.37 (7.80-11.26) | **<.0001** |'
- en: '| Hypertension |'
  id: totrans-split-286
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-287
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 6.31 (5.65-7.05) | **<.0001** |'
  id: totrans-split-288
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6.31 (5.65-7.05) | **<.0001** |'
- en: '| Diabetes |'
  id: totrans-split-289
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-290
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 10.18 (8.92-11.62) | **<.0001** |'
  id: totrans-split-291
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 10.18 (8.92-11.62) | **<.0001** |'
- en: '| Character . | OR (95% CI) . | *P* . |'
  id: totrans-split-292
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . |'
- en: '| --- | --- | --- |'
  id: totrans-split-293
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- |'
- en: '| Age, y | 1.04 (1.04-1.04) | **<.0001** |'
  id: totrans-split-294
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 | 1.04 (1.04-1.04) | **<.0001** |'
- en: '| Sex |'
  id: totrans-split-295
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |'
- en: '|  Male | Reference | Reference |'
  id: totrans-split-296
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 参考 | 参考 |'
- en: '|  Female | 1.10 (1.00-1.21) | .06 |'
  id: totrans-split-297
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.10 (1.00-1.21) | .06 |'
- en: '| Race |'
  id: totrans-split-298
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |'
- en: '|  Non-Hispanic White | Reference | Reference |'
  id: totrans-split-299
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 参考 | 参考 |'
- en: '|  Non-Hispanic Black | 0.80 (0.72-0.89) | **<.0001** |'
  id: totrans-split-300
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 0.80 (0.72-0.89) | **<.0001** |'
- en: '|  Mexican American | 0.90 (0.79-1.03) | .12 |'
  id: totrans-split-301
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 0.90 (0.79-1.03) | .12 |'
- en: '|  Other Race | 0.75 (0.65-0.85) | **<.0001** |'
  id: totrans-split-302
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 0.75 (0.65-0.85) | **<.0001** |'
- en: '| Education |'
  id: totrans-split-303
  prefs: []
  type: TYPE_TB
  zh: '| 教育 |'
- en: '|  > High school | Reference | Reference |'
  id: totrans-split-304
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 参考 | 参考 |'
- en: '|  High school | 1.45 (1.30-1.62) | **<.0001** |'
  id: totrans-split-305
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 1.45 (1.30-1.62) | **<.0001** |'
- en: '|  < High school | 1.67 (1.42-1.97) | **<.0001** |'
  id: totrans-split-306
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1.67 (1.42-1.97) | **<.0001** |'
- en: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
  id: totrans-split-307
  prefs: []
  type: TYPE_TB
  zh: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
- en: '| Waist, cm | 1.09 (1.09-1.10) | **<.0001** |'
  id: totrans-split-308
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，cm | 1.09 (1.09-1.10) | **<.0001** |'
- en: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
  id: totrans-split-309
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
- en: '|  0 | Reference | Reference |'
  id: totrans-split-310
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 参考 | 参考 |'
- en: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
  id: totrans-split-311
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
- en: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
  id: totrans-split-312
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
- en: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
  id: totrans-split-313
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
- en: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
  id: totrans-split-314
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
- en: '|  5 | 1.76 (0.32-9.56) | .51 |'
  id: totrans-split-315
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 1.76 (0.32-9.56) | .51 |'
- en: '| ALT, U/L | 1.02 (1.01-1.02) | **<.0001** |'
  id: totrans-split-316
  prefs: []
  type: TYPE_TB
  zh: '| ALT，U/L | 1.02 (1.01-1.02) | **<.0001** |'
- en: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
  id: totrans-split-317
  prefs: []
  type: TYPE_TB
  zh: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
- en: '| TGs, mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
  id: totrans-split-318
  prefs: []
  type: TYPE_TB
  zh: '| 三酰甘油，mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
- en: '| TC, mmol/L | 1.07 (1.02-1.12) | **.002** |'
  id: totrans-split-319
  prefs: []
  type: TYPE_TB
  zh: '| 总胆固醇，mmol/L | 1.07 (1.02-1.12) | **.002** |'
- en: '| HDL-c, mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
  id: totrans-split-320
  prefs: []
  type: TYPE_TB
  zh: '| 高密度脂蛋白胆固醇，mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
- en: '| LDL-c, mmol/L | 1.06 (1.01-1.11) | **.02** |'
  id: totrans-split-321
  prefs: []
  type: TYPE_TB
  zh: '| 低密度脂蛋白胆固醇，mmol/L | 1.06 (1.01-1.11) | **.02** |'
- en: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
  id: totrans-split-322
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
- en: '| HbA[1c], % | 3.82 (3.34-4.37) | **<.0001** |'
  id: totrans-split-323
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c]，% | 3.82 (3.34-4.37) | **<.0001** |'
- en: '| Ca, mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
  id: totrans-split-324
  prefs: []
  type: TYPE_TB
  zh: '| 钙，mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
- en: '| Smoking |'
  id: totrans-split-325
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-326
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 1.34 (1.23-1.45) | **<.0001** |'
  id: totrans-split-327
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.34 (1.23-1.45) | **<.0001** |'
- en: '| Drinking |'
  id: totrans-split-328
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-329
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 0.82 (0.73-0.92) | **<.001** |'
  id: totrans-split-330
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 0.82 (0.73-0.92) | **<.001** |'
- en: '| Hyperlipidemia |'
  id: totrans-split-331
  prefs: []
  type: TYPE_TB
  zh: '| 高血脂 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-332
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 9.37 (7.80-11.26) | **<.0001** |'
  id: totrans-split-333
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 9.37 (7.80-11.26) | **<.0001** |'
- en: '| Hypertension |'
  id: totrans-split-334
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-335
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 6.31 (5.65-7.05) | **<.0001** |'
  id: totrans-split-336
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6.31 (5.65-7.05) | **<.0001** |'
- en: '| Diabetes |'
  id: totrans-split-337
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-338
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 10.18 (8.92-11.62) | **<.0001** |'
  id: totrans-split-339
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 10.18 (8.92-11.62) | **<.0001** |'
- en: Table 2.
  id: totrans-split-340
  prefs: []
  type: TYPE_NORMAL
  zh: 表 2.
- en: Univariate logistics regression analysis of the association between magnesium
    depletion score and metabolic syndrome
  id: totrans-split-341
  prefs: []
  type: TYPE_NORMAL
  zh: 代谢综合征与镁缺乏分数相关的单变量逻辑回归分析
- en: '| Character . | OR (95% CI) . | *P* . |'
  id: totrans-split-342
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . |'
- en: '| --- | --- | --- |'
  id: totrans-split-343
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- |'
- en: '| Age, y | 1.04 (1.04-1.04) | **<.0001** |'
  id: totrans-split-344
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 | 1.04 (1.04-1.04) | **<.0001** |'
- en: '| Sex |'
  id: totrans-split-345
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |'
- en: '|  Male | Reference | Reference |'
  id: totrans-split-346
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 参考 | 参考 |'
- en: '|  Female | 1.10 (1.00-1.21) | .06 |'
  id: totrans-split-347
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.10 (1.00-1.21) | .06 |'
- en: '| Race |'
  id: totrans-split-348
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |'
- en: '|  Non-Hispanic White | Reference | Reference |'
  id: totrans-split-349
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 参考 | 参考 |'
- en: '|  Non-Hispanic Black | 0.80 (0.72-0.89) | **<.0001** |'
  id: totrans-split-350
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 0.80 (0.72-0.89) | **<.0001** |'
- en: '|  Mexican American | 0.90 (0.79-1.03) | .12 |'
  id: totrans-split-351
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 0.90 (0.79-1.03) | .12 |'
- en: '|  Other Race | 0.75 (0.65-0.85) | **<.0001** |'
  id: totrans-split-352
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 0.75 (0.65-0.85) | **<.0001** |'
- en: '| Education |'
  id: totrans-split-353
  prefs: []
  type: TYPE_TB
  zh: '| 教育程度 |'
- en: '|  > High school | Reference | Reference |'
  id: totrans-split-354
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 参考 | 参考 |'
- en: '|  High school | 1.45 (1.30-1.62) | **<.0001** |'
  id: totrans-split-355
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 1.45 (1.30-1.62) | **<.0001** |'
- en: '|  < High school | 1.67 (1.42-1.97) | **<.0001** |'
  id: totrans-split-356
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1.67 (1.42-1.97) | **<.0001** |'
- en: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
  id: totrans-split-357
  prefs: []
  type: TYPE_TB
  zh: '| 体质指数（BMI） | 1.19 (1.17-1.20) | **<.0001** |'
- en: '| Waist, cm | 1.09 (1.09-1.10) | **<.0001** |'
  id: totrans-split-358
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，厘米 | 1.09 (1.09-1.10) | **<.0001** |'
- en: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
  id: totrans-split-359
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
- en: '|  0 | Reference | Reference |'
  id: totrans-split-360
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 参考 | 参考 |'
- en: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
  id: totrans-split-361
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
- en: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
  id: totrans-split-362
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
- en: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
  id: totrans-split-363
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
- en: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
  id: totrans-split-364
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
- en: '|  5 | 1.76 (0.32-9.56) | .51 |'
  id: totrans-split-365
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 1.76 (0.32-9.56) | .51 |'
- en: '| ALT, U/L | 1.02 (1.01-1.02) | **<.0001** |'
  id: totrans-split-366
  prefs: []
  type: TYPE_TB
  zh: '| 谷丙转氨酶，U/L | 1.02 (1.01-1.02) | **<.0001** |'
- en: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
  id: totrans-split-367
  prefs: []
  type: TYPE_TB
  zh: '| 天门冬氨酸转氨酶，U/L | 1.01 (1.00-1.01) | **.002** |'
- en: '| TGs, mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
  id: totrans-split-368
  prefs: []
  type: TYPE_TB
  zh: '| 甘油三酯，mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
- en: '| TC, mmol/L | 1.07 (1.02-1.12) | **.002** |'
  id: totrans-split-369
  prefs: []
  type: TYPE_TB
  zh: '| 总胆固醇，mmol/L | 1.07 (1.02-1.12) | **.002** |'
- en: '| HDL-c, mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
  id: totrans-split-370
  prefs: []
  type: TYPE_TB
  zh: '| 高密度脂蛋白胆固醇，mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
- en: '| LDL-c, mmol/L | 1.06 (1.01-1.11) | **.02** |'
  id: totrans-split-371
  prefs: []
  type: TYPE_TB
  zh: '| 低密度脂蛋白胆固醇，mmol/L | 1.06 (1.01-1.11) | **.02** |'
- en: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
  id: totrans-split-372
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
- en: '| HbA[1c], % | 3.82 (3.34-4.37) | **<.0001** |'
  id: totrans-split-373
  prefs: []
  type: TYPE_TB
  zh: '| 糖化血红蛋白（HbA[1c]），% | 3.82 (3.34-4.37) | **<.0001** |'
- en: '| Ca, mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
  id: totrans-split-374
  prefs: []
  type: TYPE_TB
  zh: '| 钙，mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
- en: '| Smoking |'
  id: totrans-split-375
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-376
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 1.34 (1.23-1.45) | **<.0001** |'
  id: totrans-split-377
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.34 (1.23-1.45) | **<.0001** |'
- en: '| Drinking |'
  id: totrans-split-378
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-379
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 0.82 (0.73-0.92) | **<.001** |'
  id: totrans-split-380
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 0.82 (0.73-0.92) | **<.001** |'
- en: '| Hyperlipidemia |'
  id: totrans-split-381
  prefs: []
  type: TYPE_TB
  zh: '| 高脂血症 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-382
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 9.37 (7.80-11.26) | **<.0001** |'
  id: totrans-split-383
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 9.37 (7.80-11.26) | **<.0001** |'
- en: '| Hypertension |'
  id: totrans-split-384
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-385
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 6.31 (5.65-7.05) | **<.0001** |'
  id: totrans-split-386
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6.31 (5.65-7.05) | **<.0001** |'
- en: '| Diabetes |'
  id: totrans-split-387
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-388
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 10.18 (8.92-11.62) | **<.0001** |'
  id: totrans-split-389
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 10.18 (8.92-11.62) | **<.0001** |'
- en: '| Character . | OR (95% CI) . | *P* . |'
  id: totrans-split-390
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . |'
- en: '| --- | --- | --- |'
  id: totrans-split-391
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- |'
- en: '| Age, y | 1.04 (1.04-1.04) | **<.0001** |'
  id: totrans-split-392
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 | 1.04 (1.04-1.04) | **<.0001** |'
- en: '| Sex |'
  id: totrans-split-393
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |'
- en: '|  Male | Reference | Reference |'
  id: totrans-split-394
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 参考 | 参考 |'
- en: '|  Female | 1.10 (1.00-1.21) | .06 |'
  id: totrans-split-395
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.10 (1.00-1.21) | .06 |'
- en: '| Race |'
  id: totrans-split-396
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |'
- en: '|  Non-Hispanic White | Reference | Reference |'
  id: totrans-split-397
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 参考 | 参考 |'
- en: '|  Non-Hispanic Black | 0.80 (0.72-0.89) | **<.0001** |'
  id: totrans-split-398
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 0.80 (0.72-0.89) | **<.0001** |'
- en: '|  Mexican American | 0.90 (0.79-1.03) | .12 |'
  id: totrans-split-399
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 0.90 (0.79-1.03) | .12 |'
- en: '|  Other Race | 0.75 (0.65-0.85) | **<.0001** |'
  id: totrans-split-400
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 0.75 (0.65-0.85) | **<.0001** |'
- en: '| Education |'
  id: totrans-split-401
  prefs: []
  type: TYPE_TB
  zh: '| 教育程度 |'
- en: '|  > High school | Reference | Reference |'
  id: totrans-split-402
  prefs: []
  type: TYPE_TB
  zh: '|  > 高中 | 参考 | 参考 |'
- en: '|  High school | 1.45 (1.30-1.62) | **<.0001** |'
  id: totrans-split-403
  prefs: []
  type: TYPE_TB
  zh: '|  高中 | 1.45 (1.30-1.62) | **<.0001** |'
- en: '|  < High school | 1.67 (1.42-1.97) | **<.0001** |'
  id: totrans-split-404
  prefs: []
  type: TYPE_TB
  zh: '|  < 高中 | 1.67 (1.42-1.97) | **<.0001** |'
- en: '| BMI | 1.19 (1.17-1.20) | **<.0001** |'
  id: totrans-split-405
  prefs: []
  type: TYPE_TB
  zh: '| 体质指数（BMI） | 1.19 (1.17-1.20) | **<.0001** |'
- en: '| Waist, cm | 1.09 (1.09-1.10) | **<.0001** |'
  id: totrans-split-406
  prefs: []
  type: TYPE_TB
  zh: '| 腰围，厘米 | 1.09 (1.09-1.10) | **<.0001** |'
- en: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
  id: totrans-split-407
  prefs: []
  type: TYPE_TB
  zh: '| MDS | 1.78 (1.69-1.88) | **<.0001** |'
- en: '|  0 | Reference | Reference |'
  id: totrans-split-408
  prefs: []
  type: TYPE_TB
  zh: '|  0 | 参考 | 参考 |'
- en: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
  id: totrans-split-409
  prefs: []
  type: TYPE_TB
  zh: '|  1 | 1.41 (1.28-1.56) | **<.0001** |'
- en: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
  id: totrans-split-410
  prefs: []
  type: TYPE_TB
  zh: '|  2 | 3.12 (2.71-3.59) | **<.0001** |'
- en: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
  id: totrans-split-411
  prefs: []
  type: TYPE_TB
  zh: '|  3 | 6.59 (5.28-8.24) | **<.0001** |'
- en: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
  id: totrans-split-412
  prefs: []
  type: TYPE_TB
  zh: '|  4 | 9.05 (5.97-13.73) | **<.0001** |'
- en: '|  5 | 1.76 (0.32-9.56) | .51 |'
  id: totrans-split-413
  prefs: []
  type: TYPE_TB
  zh: '|  5 | 1.76 (0.32-9.56) | .51 |'
- en: '| ALT, U/L | 1.02 (1.01-1.02) | **<.0001** |'
  id: totrans-split-414
  prefs: []
  type: TYPE_TB
  zh: '| 谷丙转氨酶，U/L | 1.02 (1.01-1.02) | **<.0001** |'
- en: '| AST, U/L | 1.01 (1.00-1.01) | **.002** |'
  id: totrans-split-415
  prefs: []
  type: TYPE_TB
  zh: '| 天门冬氨酸转氨酶，U/L | 1.01 (1.00-1.01) | **.002** |'
- en: '| TGs, mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
  id: totrans-split-416
  prefs: []
  type: TYPE_TB
  zh: '| 甘油三酯，mmol/L | 5.42 (4.86-6.04) | **<.0001** |'
- en: '| TC, mmol/L | 1.07 (1.02-1.12) | **.002** |'
  id: totrans-split-417
  prefs: []
  type: TYPE_TB
  zh: '| TC, mmol/L | 1.07 (1.02-1.12) | **.002** |'
- en: '| HDL-c, mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
  id: totrans-split-418
  prefs: []
  type: TYPE_TB
  zh: '| HDL-c, mmol/L | 0.08 (0.07-0.10) | **<.0001** |'
- en: '| LDL-c, mmol/L | 1.06 (1.01-1.11) | **.02** |'
  id: totrans-split-419
  prefs: []
  type: TYPE_TB
  zh: '| LDL-c, mmol/L | 1.06 (1.01-1.11) | **.02** |'
- en: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
  id: totrans-split-420
  prefs: []
  type: TYPE_TB
  zh: '| HOMA-IR | 1.59 (1.53-1.65) | **<.0001** |'
- en: '| HbA[1c], % | 3.82 (3.34-4.37) | **<.0001** |'
  id: totrans-split-421
  prefs: []
  type: TYPE_TB
  zh: '| HbA[1c], % | 3.82 (3.34-4.37) | **<.0001** |'
- en: '| Ca, mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
  id: totrans-split-422
  prefs: []
  type: TYPE_TB
  zh: '| 钙, mg/dL | 2.29 (1.96-2.68) | **<.0001** |'
- en: '| Smoking |'
  id: totrans-split-423
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-424
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 1.34 (1.23-1.45) | **<.0001** |'
  id: totrans-split-425
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.34 (1.23-1.45) | **<.0001** |'
- en: '| Drinking |'
  id: totrans-split-426
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-427
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 0.82 (0.73-0.92) | **<.001** |'
  id: totrans-split-428
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 0.82 (0.73-0.92) | **<.001** |'
- en: '| Hyperlipidemia |'
  id: totrans-split-429
  prefs: []
  type: TYPE_TB
  zh: '| 高脂血症 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-430
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 9.37 (7.80-11.26) | **<.0001** |'
  id: totrans-split-431
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 9.37 (7.80-11.26) | **<.0001** |'
- en: '| Hypertension |'
  id: totrans-split-432
  prefs: []
  type: TYPE_TB
  zh: '| 高血压 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-433
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 6.31 (5.65-7.05) | **<.0001** |'
  id: totrans-split-434
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 6.31 (5.65-7.05) | **<.0001** |'
- en: '| Diabetes |'
  id: totrans-split-435
  prefs: []
  type: TYPE_TB
  zh: '| 糖尿病 |'
- en: '|  No | Reference | Reference |'
  id: totrans-split-436
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 参考 | 参考 |'
- en: '|  Yes | 10.18 (8.92-11.62) | **<.0001** |'
  id: totrans-split-437
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 10.18 (8.92-11.62) | **<.0001** |'
- en: Multivariable Logistic Regression Models for the Association Between Magnesium
    Depletion Score and Metabolic Syndrome
  id: totrans-split-438
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 关于镁缺乏分数与代谢综合征之间关联的多变量 Logistic 回归模型
- en: Table 3 presents the results of multivariable logistic regression analysis of
    the association between MDS and MetS using 4 models. In the crude model without
    adjustments, a higher MDS was significantly associated with increased odds of
    MetS. The OR (95% CI) for each 1-unit increase in MDS was 1.78 (1.69-1.88). When
    MDS was categorized into 6 levels, there was a graded increase in the odds of
    MetS with increasing MDS (*P* for trend <.0001). After adjusting for demographics
    (age, sex, race, and education) in model 1, the association between MDS and MetS
    was attenuated but remained significant. The OR (95% CI) for each 1-unit increase
    in MDS was 1.33 (1.25-1.41). The odds were also significantly higher for MDS levels
    2 to 4 compared to MDS = 0\. With further adjustments for various cardiometabolic
    factors in models 2 and 3, the association between MDS and MetS persisted. In
    the fully adjusted model 3, the OR (95% CI) for each 1-unit increase in MDS was
    1.31 (1.17-1.45). MDS levels 1 to 4 remained significantly associated with higher
    odds of MetS compared to MDS = 0 after full adjustments (all *P* < .05).
  id: totrans-split-439
  prefs: []
  type: TYPE_NORMAL
  zh: 表 3 展示了关于 MDS 和 MetS 之间关联的多变量 logistic 回归分析结果，使用了 4 个模型。在未经调整的原始模型中，较高的 MDS
    显著与 MetS 的发病率增加相关。每增加 1 个 MDS 单位的 OR（95% CI）为 1.78 (1.69-1.88)。将 MDS 分为 6 个级别后，随着
    MDS 的增加，MetS 的发病率呈递增趋势（*P* for trend <.0001）。在模型 1 中根据人口统计学数据（年龄、性别、种族和教育水平）调整后，MDS
    与 MetS 之间的关联减弱但仍显著。每增加 1 个 MDS 单位的 OR（95% CI）为 1.33 (1.25-1.41)。在模型 2 和模型 3 中进一步调整了各种心血管代谢因子后，MDS
    与 MetS 之间的关联仍然存在。在完全调整的模型 3 中，每增加 1 个 MDS 单位的 OR（95% CI）为 1.31 (1.17-1.45)。与 MDS
    = 0 相比，MDS 级别 1 到 4 在完全调整后仍然显著与较高的 MetS 发病率相关（所有 *P* < .05）。
- en: Table 3.
  id: totrans-split-440
  prefs: []
  type: TYPE_NORMAL
  zh: 表 3.
- en: Multivariable logistics regression analysis of the association between magnesium
    depletion score and metabolic syndrome
  id: totrans-split-441
  prefs: []
  type: TYPE_NORMAL
  zh: 镁缺乏分数与代谢综合征之间的多变量 logistic 回归分析
- en: '| Character . | Model . |'
  id: totrans-split-442
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | 模型 . |'
- en: '| --- | --- |'
  id: totrans-split-443
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- |'
- en: '| Crude model . | Model 1 . | Model 2 . | Model 3 . |'
  id: totrans-split-444
  prefs: []
  type: TYPE_TB
  zh: '| 原始模型 . | 模型 1 . | 模型 2 . | 模型 3 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-445
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
  id: totrans-split-446
  prefs: []
  type: TYPE_TB
  zh: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
- en: '| --- | --- | --- | --- | --- | --- | --- | --- |'
  id: totrans-split-447
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- | --- | --- | --- |'
- en: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
  id: totrans-split-448
  prefs: []
  type: TYPE_TB
  zh: '| 总计 | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
- en: '| 0 | Reference |  | Reference |  | Reference |  | Reference |  |'
  id: totrans-split-449
  prefs: []
  type: TYPE_TB
  zh: '| 0 | 参考 |  | 参考 |  | 参考 |  | 参考 |  |'
- en: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
  id: totrans-split-450
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
- en: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
  id: totrans-split-451
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
- en: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
  id: totrans-split-452
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
- en: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
  id: totrans-split-453
  prefs: []
  type: TYPE_TB
  zh: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
- en: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
  id: totrans-split-454
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
- en: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
  id: totrans-split-455
  prefs: []
  type: TYPE_TB
  zh: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
- en: '| Character . | Model . |'
  id: totrans-split-456
  prefs: []
  type: TYPE_TB
  zh: '| 特性 . | 模型 . |'
- en: '| --- | --- |'
  id: totrans-split-457
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- |'
- en: '| Crude model . | Model 1 . | Model 2 . | Model 3 . |'
  id: totrans-split-458
  prefs: []
  type: TYPE_TB
  zh: '| 粗略模型 . | 模型 1 . | 模型 2 . | 模型 3 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-459
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
  id: totrans-split-460
  prefs: []
  type: TYPE_TB
  zh: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
- en: '| --- | --- | --- | --- | --- | --- | --- | --- |'
  id: totrans-split-461
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- | --- | --- | --- |'
- en: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
  id: totrans-split-462
  prefs: []
  type: TYPE_TB
  zh: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
- en: '| 0 | Reference |  | Reference |  | Reference |  | Reference |  |'
  id: totrans-split-463
  prefs: []
  type: TYPE_TB
  zh: '| 0 | 参考 |  | 参考 |  | 参考 |  | 参考 |  |'
- en: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
  id: totrans-split-464
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
- en: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
  id: totrans-split-465
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
- en: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
  id: totrans-split-466
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
- en: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
  id: totrans-split-467
  prefs: []
  type: TYPE_TB
  zh: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
- en: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
  id: totrans-split-468
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
- en: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
  id: totrans-split-469
  prefs: []
  type: TYPE_TB
  zh: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
- en: Table 3.
  id: totrans-split-470
  prefs: []
  type: TYPE_NORMAL
  zh: 表 3.
- en: Multivariable logistics regression analysis of the association between magnesium
    depletion score and metabolic syndrome
  id: totrans-split-471
  prefs: []
  type: TYPE_NORMAL
  zh: 镁缺乏分数与代谢综合征的多变量逻辑回归分析
- en: '| Character . | Model . |'
  id: totrans-split-472
  prefs: []
  type: TYPE_TB
  zh: '| 特性 . | 模型 . |'
- en: '| --- | --- |'
  id: totrans-split-473
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- |'
- en: '| Crude model . | Model 1 . | Model 2 . | Model 3 . |'
  id: totrans-split-474
  prefs: []
  type: TYPE_TB
  zh: '| 粗略模型 . | 模型 1 . | 模型 2 . | 模型 3 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-475
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
  id: totrans-split-476
  prefs: []
  type: TYPE_TB
  zh: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
- en: '| --- | --- | --- | --- | --- | --- | --- | --- |'
  id: totrans-split-477
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- | --- | --- | --- |'
- en: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
  id: totrans-split-478
  prefs: []
  type: TYPE_TB
  zh: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
- en: '| 0 | Reference |  | Reference |  | Reference |  | Reference |  |'
  id: totrans-split-479
  prefs: []
  type: TYPE_TB
  zh: '| 0 | 参考 |  | 参考 |  | 参考 |  | 参考 |  |'
- en: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
  id: totrans-split-480
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
- en: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
  id: totrans-split-481
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
- en: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
  id: totrans-split-482
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
- en: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
  id: totrans-split-483
  prefs: []
  type: TYPE_TB
  zh: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
- en: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
  id: totrans-split-484
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
- en: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
  id: totrans-split-485
  prefs: []
  type: TYPE_TB
  zh: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
- en: '| Character . | Model . |'
  id: totrans-split-486
  prefs: []
  type: TYPE_TB
  zh: '| 特性 . | 模型 . |'
- en: '| --- | --- |'
  id: totrans-split-487
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- |'
- en: '| Crude model . | Model 1 . | Model 2 . | Model 3 . |'
  id: totrans-split-488
  prefs: []
  type: TYPE_TB
  zh: '| 粗略模型 . | 模型 1 . | 模型 2 . | 模型 3 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-489
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
  id: totrans-split-490
  prefs: []
  type: TYPE_TB
  zh: '| 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* . | 95% CI . | *P* .
    |'
- en: '| --- | --- | --- | --- | --- | --- | --- | --- |'
  id: totrans-split-491
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- | --- | --- | --- | --- |'
- en: '| Total | 1.78 (1.69-1.88) | **<.0001** | 1.33 (1.25-1.41) | **<.0001** | 1.51
    (1.37-1.67) | **<.0001** | 1.31 (1.17-1.45) | **<.0001** |'
  id: totrans-split-492
  prefs: []
  type: TYPE_TB
  zh: '| 总数 | 1.78（1.69-1.88） | **<.0001** | 1.33（1.25-1.41） | **<.0001** | 1.51（1.37-1.67）
    | **<.0001** | 1.31（1.17-1.45） | **<.0001** |'
- en: '| 0 | Reference |  | Reference |  | Reference |  | Reference |  |'
  id: totrans-split-493
  prefs: []
  type: TYPE_TB
  zh: '| 0 | 参考 |  | 参考 |  | 参考 |  | 参考 |  |'
- en: '| 1 | 1.41 (1.28-1.56) | **<.0001** | 1.00 (0.89-1.11) | .96 | 1.32 (1.10-1.57)
    | **.003** | 1.28 (1.06-1.55) | **.01** |'
  id: totrans-split-494
  prefs: []
  type: TYPE_TB
  zh: '| 1 | 1.41（1.28-1.56） | **<.0001** | 1.00（0.89-1.11） | .96 | 1.32（1.10-1.57）
    | **.003** | 1.28（1.06-1.55） | **.01** |'
- en: '| 2 | 3.12 (2.71-3.59) | **<.0001** | 1.60 (1.37-1.87) | **<.0001** | 2.10
    (1.65-2.68) | **<.0001** | 1.57 (1.22-2.03) | **<.001** |'
  id: totrans-split-495
  prefs: []
  type: TYPE_TB
  zh: '| 2 | 3.12（2.71-3.59） | **<.0001** | 1.60（1.37-1.87） | **<.0001** | 2.10（1.65-2.68）
    | **<.0001** | 1.57（1.22-2.03） | **<.001** |'
- en: '| 3 | 6.59 (5.28-8.24) | **<.0001** | 2.70 (2.09-3.48) | **<.0001** | 4.19
    (2.78-6.33) | **<.0001** | 2.60 (1.69-4.02) | **<.0001** |'
  id: totrans-split-496
  prefs: []
  type: TYPE_TB
  zh: '| 3 | 6.59（5.28-8.24） | **<.0001** | 2.70（2.09-3.48） | **<.0001** | 4.19（2.78-6.33）
    | **<.0001** | 2.60（1.69-4.02） | **<.0001** |'
- en: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
  id: totrans-split-497
  prefs: []
  type: TYPE_TB
  zh: '| 4 | 9.05 (5.97-13.73) | **<.0001** | 3.49 (2.24-5.44) | **<.0001** | 4.76
    (2.53-8.94) | **<.0001** | 2.83 (1.42-5.61) | **.003** |'
- en: '| 5 | 1.76 (0.32-9.56) | .51 | 0.59 (0.10-3.36) | .55 | 1.39 (0.12-15.59) |
    .79 | 0.88 (0.07-11.47) | .92 |'
  id: totrans-split-498
  prefs: []
  type: TYPE_TB
  zh: '| 5 | 1.76（0.32-9.56） | .51 | 0.59（0.10-3.36） | .55 | 1.39（0.12-15.59） | .79
    | 0.88（0.07-11.47） | .92 |'
- en: '| *P* for trend |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001**
    |'
  id: totrans-split-499
  prefs: []
  type: TYPE_TB
  zh: '| *P* 趋势 |  | **<.0001** |  | **<.0001** |  | **<.0001** |  | **<.0001** |'
- en: Stratified Analysis of the Association Between Magnesium Depletion Score and
    Metabolic Syndrome
  id: totrans-split-500
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: Stratified Analysis of the Association Between Magnesium Depletion Score and
    Metabolic Syndrome
- en: This study examined the association between MDS and MetS across subgroups defined
    by age, sex, race, BMI, drinking status, and smoking status using multivariable
    logistic regression analysis adjusted for potential confounders (Table 4). MDS
    was significantly associated with increased odds of MetS in most subgroups, with
    ORs ranging from 1.19 to 1.60 per 1-unit MDS increase. The association was not
    significant only in the Mexican American subgroup (*P* = .08). There was no significant
    interaction detected between MDS and subgroups, indicating the positive MDS-MetS
    relationship was consistent across diverse population segments. Overall, these
    findings demonstrate that higher magnesium deficiency status as reflected by MDS
    is a robust independent risk factor for MetS irrespective of sociodemographic
    and lifestyle factors in US adults.
  id: totrans-split-501
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究使用多变量 logistic 回归分析检验了 MDS 与 MetS 之间的关联，跨年龄、性别、种族、BMI、饮酒状态和吸烟状态的亚组定义进行了分层分析（表
    4）。MDS 与 MetS 的相关性在大多数亚组中都显著，每增加 1 单位 MDS，OR 值从 1.19 到 1.60 不等。仅在墨西哥裔美国人亚组中相关性不显著（*P*
    = .08）。MDS 与亚组之间未检测到显著互动，表明在美国成年人群中，不论社会人口统计学和生活方式因素如何，由 MDS 反映的镁缺乏状态均是 MetS 的独立风险因素。
- en: Table 4.
  id: totrans-split-502
  prefs: []
  type: TYPE_NORMAL
  zh: Table 4.
- en: Subgroup analysis for the association between magnesium depletion score and
    metabolic syndrome
  id: totrans-split-503
  prefs: []
  type: TYPE_NORMAL
  zh: 与代谢综合征相关的镁耗尽得分的亚组分析
- en: '| Character . | OR (95% CI) . | *P* . | *P* for interaction . |'
  id: totrans-split-504
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR（95% CI）. | *P* . | *P* 互动 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-505
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| Age, y |  |  | .33 |'
  id: totrans-split-506
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 |  |  | .33 |'
- en: '|  <40 | 1.26 (1.01-1.58) | **.04** |  |'
  id: totrans-split-507
  prefs: []
  type: TYPE_TB
  zh: '|  <40 | 1.26（1.01-1.58） | **.04** |  |'
- en: '|  40-60 | 1.28 (1.09-1.51) | **.003** |  |'
  id: totrans-split-508
  prefs: []
  type: TYPE_TB
  zh: '|  40-60 | 1.28（1.09-1.51） | **.003** |  |'
- en: '|  >60 | 1.33 (1.18-1.51) | **<.0001** |  |'
  id: totrans-split-509
  prefs: []
  type: TYPE_TB
  zh: '|  >60 | 1.33（1.18-1.51） | **<.0001** |  |'
- en: '| Sex |  |  | .46 |'
  id: totrans-split-510
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  | .46 |'
- en: '|  Male | 1.60 (1.40-1.83) | **<.0001** |  |'
  id: totrans-split-511
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 1.60（1.40-1.83） | **<.0001** |  |'
- en: '|  Female | 1.48 (1.30-1.69) | **<.0001** |  |'
  id: totrans-split-512
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.48（1.30-1.69） | **<.0001** |  |'
- en: '| Race |  |  | .27 |'
  id: totrans-split-513
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  | .27 |'
- en: '|  Non-Hispanic White | 1.51 (1.34-1.70) | **<.0001** |  |'
  id: totrans-split-514
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 1.51（1.34-1.70） | **<.0001** |  |'
- en: '|  Non-Hispanic Black | 1.38 (1.22-1.56) | **<.0001** |  |'
  id: totrans-split-515
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 1.38（1.22-1.56） | **<.0001** |  |'
- en: '|  Mexican American | 1.19 (0.98-1.46) | .08 |  |'
  id: totrans-split-516
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 1.19（0.98-1.46） | .08 |  |'
- en: '|  Other race | 1.37 (1.13-1.65) | **.001** |  |'
  id: totrans-split-517
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 1.37（1.13-1.65） | **.001** |  |'
- en: '| BMI |  |  | .92 |'
  id: totrans-split-518
  prefs: []
  type: TYPE_TB
  zh: '| BMI |  |  | .92 |'
- en: '|  Normal | 1.33 (1.02-1.74) | **.03** |  |'
  id: totrans-split-519
  prefs: []
  type: TYPE_TB
  zh: '|  正常 | 1.33（1.02-1.74） | **.03** |  |'
- en: '|  Unnormal | 1.50 (1.36-1.64) | **<.0001** |  |'
  id: totrans-split-520
  prefs: []
  type: TYPE_TB
  zh: '|  不正常 | 1.50（1.36-1.64） | **<.0001** |  |'
- en: '| Drinking |  |  | .27 |'
  id: totrans-split-521
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  | .27 |'
- en: '|  No | 1.43 (1.19-1.73) | **<.001** |  |'
  id: totrans-split-522
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.43（1.19-1.73） | **<.001** |  |'
- en: '|  Yes | 1.50 (1.37-1.64) | **<.0001** |  |'
  id: totrans-split-523
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.50（1.37-1.64） | **<.0001** |  |'
- en: '| Smoking |  |  | .75 |'
  id: totrans-split-524
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  | .75 |'
- en: '|  No | 1.57 (1.38-1.78) | **<.0001** |  |'
  id: totrans-split-525
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.57（1.38-1.78） | **<.0001** |  |'
- en: '|  Yes | 1.42 (1.26-1.60) | **<.0001** |  |'
  id: totrans-split-526
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.42（1.26-1.60） | **<.0001** |  |'
- en: '| Character . | OR (95% CI) . | *P* . | *P* for interaction . |'
  id: totrans-split-527
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR（95% CI）. | *P* . | *P* 互动 . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-528
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| Age, y |  |  | .33 |'
  id: totrans-split-529
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 |  |  | .33 |'
- en: '|  <40 | 1.26 (1.01-1.58) | **.04** |  |'
  id: totrans-split-530
  prefs: []
  type: TYPE_TB
  zh: '|  <40岁 | 1.26 (1.01-1.58) | **.04** |  |'
- en: '|  40-60 | 1.28 (1.09-1.51) | **.003** |  |'
  id: totrans-split-531
  prefs: []
  type: TYPE_TB
  zh: '|  40-60岁 | 1.28 (1.09-1.51) | **.003** |  |'
- en: '|  >60 | 1.33 (1.18-1.51) | **<.0001** |  |'
  id: totrans-split-532
  prefs: []
  type: TYPE_TB
  zh: '|  >60岁 | 1.33 (1.18-1.51) | **<.0001** |  |'
- en: '| Sex |  |  | .46 |'
  id: totrans-split-533
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  | .46 |'
- en: '|  Male | 1.60 (1.40-1.83) | **<.0001** |  |'
  id: totrans-split-534
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 1.60 (1.40-1.83) | **<.0001** |  |'
- en: '|  Female | 1.48 (1.30-1.69) | **<.0001** |  |'
  id: totrans-split-535
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.48 (1.30-1.69) | **<.0001** |  |'
- en: '| Race |  |  | .27 |'
  id: totrans-split-536
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  | .27 |'
- en: '|  Non-Hispanic White | 1.51 (1.34-1.70) | **<.0001** |  |'
  id: totrans-split-537
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 1.51 (1.34-1.70) | **<.0001** |  |'
- en: '|  Non-Hispanic Black | 1.38 (1.22-1.56) | **<.0001** |  |'
  id: totrans-split-538
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 1.38 (1.22-1.56) | **<.0001** |  |'
- en: '|  Mexican American | 1.19 (0.98-1.46) | .08 |  |'
  id: totrans-split-539
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 1.19 (0.98-1.46) | .08 |  |'
- en: '|  Other race | 1.37 (1.13-1.65) | **.001** |  |'
  id: totrans-split-540
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 1.37 (1.13-1.65) | **.001** |  |'
- en: '| BMI |  |  | .92 |'
  id: totrans-split-541
  prefs: []
  type: TYPE_TB
  zh: '| BMI |  |  | .92 |'
- en: '|  Normal | 1.33 (1.02-1.74) | **.03** |  |'
  id: totrans-split-542
  prefs: []
  type: TYPE_TB
  zh: '|  正常 | 1.33 (1.02-1.74) | **.03** |  |'
- en: '|  Unnormal | 1.50 (1.36-1.64) | **<.0001** |  |'
  id: totrans-split-543
  prefs: []
  type: TYPE_TB
  zh: '|  异常 | 1.50 (1.36-1.64) | **<.0001** |  |'
- en: '| Drinking |  |  | .27 |'
  id: totrans-split-544
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  | .27 |'
- en: '|  No | 1.43 (1.19-1.73) | **<.001** |  |'
  id: totrans-split-545
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.43 (1.19-1.73) | **<.001** |  |'
- en: '|  Yes | 1.50 (1.37-1.64) | **<.0001** |  |'
  id: totrans-split-546
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.50 (1.37-1.64) | **<.0001** |  |'
- en: '| Smoking |  |  | .75 |'
  id: totrans-split-547
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  | .75 |'
- en: '|  No | 1.57 (1.38-1.78) | **<.0001** |  |'
  id: totrans-split-548
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.57 (1.38-1.78) | **<.0001** |  |'
- en: '|  Yes | 1.42 (1.26-1.60) | **<.0001** |  |'
  id: totrans-split-549
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.42 (1.26-1.60) | **<.0001** |  |'
- en: Table 4.
  id: totrans-split-550
  prefs: []
  type: TYPE_NORMAL
  zh: 表4.
- en: Subgroup analysis for the association between magnesium depletion score and
    metabolic syndrome
  id: totrans-split-551
  prefs: []
  type: TYPE_NORMAL
  zh: 镁缺乏分数与代谢综合征的亚组分析
- en: '| Character . | OR (95% CI) . | *P* . | *P* for interaction . |'
  id: totrans-split-552
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . | *交互作用的P* . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-553
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| Age, y |  |  | .33 |'
  id: totrans-split-554
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 |  |  | .33 |'
- en: '|  <40 | 1.26 (1.01-1.58) | **.04** |  |'
  id: totrans-split-555
  prefs: []
  type: TYPE_TB
  zh: '|  <40岁 | 1.26 (1.01-1.58) | **.04** |  |'
- en: '|  40-60 | 1.28 (1.09-1.51) | **.003** |  |'
  id: totrans-split-556
  prefs: []
  type: TYPE_TB
  zh: '|  40-60岁 | 1.28 (1.09-1.51) | **.003** |  |'
- en: '|  >60 | 1.33 (1.18-1.51) | **<.0001** |  |'
  id: totrans-split-557
  prefs: []
  type: TYPE_TB
  zh: '|  >60岁 | 1.33 (1.18-1.51) | **<.0001** |  |'
- en: '| Sex |  |  | .46 |'
  id: totrans-split-558
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  | .46 |'
- en: '|  Male | 1.60 (1.40-1.83) | **<.0001** |  |'
  id: totrans-split-559
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 1.60 (1.40-1.83) | **<.0001** |  |'
- en: '|  Female | 1.48 (1.30-1.69) | **<.0001** |  |'
  id: totrans-split-560
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.48 (1.30-1.69) | **<.0001** |  |'
- en: '| Race |  |  | .27 |'
  id: totrans-split-561
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  | .27 |'
- en: '|  Non-Hispanic White | 1.51 (1.34-1.70) | **<.0001** |  |'
  id: totrans-split-562
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 1.51 (1.34-1.70) | **<.0001** |  |'
- en: '|  Non-Hispanic Black | 1.38 (1.22-1.56) | **<.0001** |  |'
  id: totrans-split-563
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 1.38 (1.22-1.56) | **<.0001** |  |'
- en: '|  Mexican American | 1.19 (0.98-1.46) | .08 |  |'
  id: totrans-split-564
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 1.19 (0.98-1.46) | .08 |  |'
- en: '|  Other race | 1.37 (1.13-1.65) | **.001** |  |'
  id: totrans-split-565
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 1.37 (1.13-1.65) | **.001** |  |'
- en: '| BMI |  |  | .92 |'
  id: totrans-split-566
  prefs: []
  type: TYPE_TB
  zh: '| BMI |  |  | .92 |'
- en: '|  Normal | 1.33 (1.02-1.74) | **.03** |  |'
  id: totrans-split-567
  prefs: []
  type: TYPE_TB
  zh: '|  正常 | 1.33 (1.02-1.74) | **.03** |  |'
- en: '|  Unnormal | 1.50 (1.36-1.64) | **<.0001** |  |'
  id: totrans-split-568
  prefs: []
  type: TYPE_TB
  zh: '|  异常 | 1.50 (1.36-1.64) | **<.0001** |  |'
- en: '| Drinking |  |  | .27 |'
  id: totrans-split-569
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  | .27 |'
- en: '|  No | 1.43 (1.19-1.73) | **<.001** |  |'
  id: totrans-split-570
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.43 (1.19-1.73) | **<.001** |  |'
- en: '|  Yes | 1.50 (1.37-1.64) | **<.0001** |  |'
  id: totrans-split-571
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.50 (1.37-1.64) | **<.0001** |  |'
- en: '| Smoking |  |  | .75 |'
  id: totrans-split-572
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  | .75 |'
- en: '|  No | 1.57 (1.38-1.78) | **<.0001** |  |'
  id: totrans-split-573
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.57 (1.38-1.78) | **<.0001** |  |'
- en: '|  Yes | 1.42 (1.26-1.60) | **<.0001** |  |'
  id: totrans-split-574
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.42 (1.26-1.60) | **<.0001** |  |'
- en: '| Character . | OR (95% CI) . | *P* . | *P* for interaction . |'
  id: totrans-split-575
  prefs: []
  type: TYPE_TB
  zh: '| 字符 . | OR (95% CI) . | *P* . | *交互作用的P* . |'
- en: '| --- | --- | --- | --- |'
  id: totrans-split-576
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- | --- |'
- en: '| Age, y |  |  | .33 |'
  id: totrans-split-577
  prefs: []
  type: TYPE_TB
  zh: '| 年龄，岁 |  |  | .33 |'
- en: '|  <40 | 1.26 (1.01-1.58) | **.04** |  |'
  id: totrans-split-578
  prefs: []
  type: TYPE_TB
  zh: '|  <40岁 | 1.26 (1.01-1.58) | **.04** |  |'
- en: '|  40-60 | 1.28 (1.09-1.51) | **.003** |  |'
  id: totrans-split-579
  prefs: []
  type: TYPE_TB
  zh: '|  40-60岁 | 1.28 (1.09-1.51) | **.003** |  |'
- en: '|  >60 | 1.33 (1.18-1.51) | **<.0001** |  |'
  id: totrans-split-580
  prefs: []
  type: TYPE_TB
  zh: '|  >60岁 | 1.33 (1.18-1.51) | **<.0001** |  |'
- en: '| Sex |  |  | .46 |'
  id: totrans-split-581
  prefs: []
  type: TYPE_TB
  zh: '| 性别 |  |  | .46 |'
- en: '|  Male | 1.60 (1.40-1.83) | **<.0001** |  |'
  id: totrans-split-582
  prefs: []
  type: TYPE_TB
  zh: '|  男性 | 1.60 (1.40-1.83) | **<.0001** |  |'
- en: '|  Female | 1.48 (1.30-1.69) | **<.0001** |  |'
  id: totrans-split-583
  prefs: []
  type: TYPE_TB
  zh: '|  女性 | 1.48 (1.30-1.69) | **<.0001** |  |'
- en: '| Race |  |  | .27 |'
  id: totrans-split-584
  prefs: []
  type: TYPE_TB
  zh: '| 种族 |  |  | .27 |'
- en: '|  Non-Hispanic White | 1.51 (1.34-1.70) | **<.0001** |  |'
  id: totrans-split-585
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔白人 | 1.51 (1.34-1.70) | **<.0001** |  |'
- en: '|  Non-Hispanic Black | 1.38 (1.22-1.56) | **<.0001** |  |'
  id: totrans-split-586
  prefs: []
  type: TYPE_TB
  zh: '|  非西班牙裔黑人 | 1.38 (1.22-1.56) | **<.0001** |  |'
- en: '|  Mexican American | 1.19 (0.98-1.46) | .08 |  |'
  id: totrans-split-587
  prefs: []
  type: TYPE_TB
  zh: '|  墨西哥裔美国人 | 1.19 (0.98-1.46) | .08 |  |'
- en: '|  Other race | 1.37 (1.13-1.65) | **.001** |  |'
  id: totrans-split-588
  prefs: []
  type: TYPE_TB
  zh: '|  其他种族 | 1.37 (1.13-1.65) | **.001** |  |'
- en: '| BMI |  |  | .92 |'
  id: totrans-split-589
  prefs: []
  type: TYPE_TB
  zh: '| BMI |  |  | .92 |'
- en: '|  Normal | 1.33 (1.02-1.74) | **.03** |  |'
  id: totrans-split-590
  prefs: []
  type: TYPE_TB
  zh: '|  正常 | 1.33 (1.02-1.74) | **.03** |  |'
- en: '|  Unnormal | 1.50 (1.36-1.64) | **<.0001** |  |'
  id: totrans-split-591
  prefs: []
  type: TYPE_TB
  zh: '|  异常 | 1.50 (1.36-1.64) | **<.0001** |  |'
- en: '| Drinking |  |  | .27 |'
  id: totrans-split-592
  prefs: []
  type: TYPE_TB
  zh: '| 饮酒 |  |  | .27 |'
- en: '|  No | 1.43 (1.19-1.73) | **<.001** |  |'
  id: totrans-split-593
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.43 (1.19-1.73) | **<.001** |  |'
- en: '|  Yes | 1.50 (1.37-1.64) | **<.0001** |  |'
  id: totrans-split-594
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.50 (1.37-1.64) | **<.0001** |  |'
- en: '| Smoking |  |  | .75 |'
  id: totrans-split-595
  prefs: []
  type: TYPE_TB
  zh: '| 吸烟 |  |  | .75 |'
- en: '|  No | 1.57 (1.38-1.78) | **<.0001** |  |'
  id: totrans-split-596
  prefs: []
  type: TYPE_TB
  zh: '|  否 | 1.57 (1.38-1.78) | **<.0001** |  |'
- en: '|  Yes | 1.42 (1.26-1.60) | **<.0001** |  |'
  id: totrans-split-597
  prefs: []
  type: TYPE_TB
  zh: '|  是 | 1.42 (1.26-1.60) | **<.0001** |  |'
- en: 'Magnesium Depletion Score and Odds of Metabolic Syndrome: A Restricted Cubic
    Spline Analysis'
  id: totrans-split-598
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 镁缺乏分数与代谢综合征的几率：受限制的立方样条分析
- en: As shown in Fig. 2, RCS was drawn to visually describe the relationship between
    MDS and MetS. The OR increased steadily with higher MDS up to a level of around
    4, where the OR peaked. Beyond MDS of 4, the OR plateaued and slightly declined
    with further increases in MDS. The *P* value for a nonlinear relationship was
    greater than .05, indicating there was no statistically significant evidence of
    nonlinearity between MDS and MetS odds. Although the OR appeared to peak at MDS
    of 4, the overall relationship can be considered linear given the nonsignificant
    test for nonlinearity. In summary, this figure demonstrates an approximately linear-positive
    association between higher MDS and increased odds of MetS, without clear threshold
    effects.
  id: totrans-split-599
  prefs: []
  type: TYPE_NORMAL
  zh: 如图2所示，RCS用于直观描述MDS与MetS之间的关系。随着MDS的增加，OR逐渐上升，直到达到约4的水平，OR达到峰值。超过MDS为4后，OR趋于平稳，并随着MDS的进一步增加略微下降。非线性关系的*P*值大于0.05，表明在MDS和MetS之间没有统计学显著的非线性证据。尽管OR在MDS为4时似乎达到峰值，但考虑到非显著的非线性检验，总体关系可以视为线性。总之，该图表明较高的MDS与增加的MetS风险之间存在近似线性正相关，而没有明确的阈值效应。
- en: Figure 2.
  id: totrans-split-600
  prefs: []
  type: TYPE_NORMAL
  zh: 图2。
- en: Nonlinear associations between magnesium depletion score (MDS) and risk of metabolic
    syndrome (MetS). The restricted cubic spline plot between MDS and MetS. The x-axis
    represents MDS, while the y-axis represents the odds ratio (OR) and the 95% CI
    for MetS. The dashed line indicates an OR of 1, which represents no association
    between MDS and MetS risk. The model adjusted by age, sex, race, body mass index,
    waist, alanine transaminase, aspartate transaminase, triglycerides, total cholesterol,
    high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, homeostatic
    model assessment for insulin resistance, glycated hemoglobin A[1c], corrected
    calcium, smoking, drinking, hyperlipidemia, diabetes, and hypertension.
  id: totrans-split-601
  prefs: []
  type: TYPE_NORMAL
  zh: 镁耗竭评分（MDS）与代谢综合征（MetS）风险之间的非线性关联。MDS与MetS之间的限制性立方样条图。X轴表示MDS，Y轴表示MetS的比值比（OR）和95%的置信区间（CI）。虚线表示OR为1，表示MDS与MetS风险之间没有关联。该模型根据年龄、性别、种族、体重指数、腰围、丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、甘油三酯、总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、胰岛素抵抗的家庭模型评估、糖化血红蛋白A[1c]、校正钙、吸烟、饮酒、高脂血症、糖尿病和高血压进行了调整。
- en: Discussion
  id: totrans-split-602
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 讨论
- en: Based on NHANES data from 2003 to 2018, we investigated the relationship between
    MetS and MDS among US adults. We found that higher MDS, indicative of greater
    urinary magnesium loss, was independently associated with increased likelihood
    of MetS. We observed a graded dose-response relationship between MDS and the odds
    of MetS, with no evidence of a threshold effect. The positive correlation between
    MDS and MetS remained significant even after adjusting for potential sociodemographic,
    lifestyle, and cardiometabolic confounders. This association was consistently
    observed across various subgroups defined by age, sex, race, BMI, drinking status,
    and smoking status.
  id: totrans-split-603
  prefs: []
  type: TYPE_NORMAL
  zh: 基于2003年至2018年的NHANES数据，我们研究了美国成年人中代谢综合征（MetS）与镁代谢指标（MDS）之间的关系。我们发现，较高的MDS，表明尿中镁丢失更多，与MetS的发生风险显著相关。我们观察到MDS与MetS之间存在逐渐增加的剂量-反应关系，没有阈值效应的证据。即使在考虑到潜在社会人口统计学、生活方式和心脑血管代谢混杂因素后，MDS与MetS的正相关关系仍然显著。这种关联在不同年龄、性别、种族、BMI、饮酒和吸烟状态定义的各个亚组中都一致存在。
- en: MetS is a constellation of multiple risk factors, including insulin resistance,
    dyslipidemia, hypertension, and adiposity (17). Magnesium is an essential nutrient
    for maintaining vital physiological functions. Numerous studies have investigated
    the relationship between MetS and magnesium. An increasing body of evidence suggests
    that chronic hypomagnesemia may play a role in the pathogenesis of various metabolic
    disorders, including overweight and obesity, insulin resistance, and type 2 diabetes
    mellitus, hypertension, alterations in lipid metabolism, and low-grade inflammation
    (18-20). A randomized, double-blind, placebo-controlled clinical trial show that
    oral magnesium supplementation improves incident MetS with a significant reduction
    in high blood pressure, hyperglycemia, and hypertriglyceridemia (21). In conclusion,
    magnesium plays a substantial role in MetS occurrence and development.
  id: totrans-split-604
  prefs: []
  type: TYPE_NORMAL
  zh: MetS 是包括胰岛素抵抗、血脂异常、高血压和肥胖在内的多种危险因素的综合体（17）。镁是维持重要生理功能的必需营养素。大量研究探讨了 MetS 与镁之间的关系。越来越多的证据表明，慢性低镁血症可能在各种代谢紊乱的发病机制中发挥作用，包括超重和肥胖、胰岛素抵抗和2型糖尿病、高血压、脂质代谢改变以及低度炎症（18-20）。一项随机、双盲、安慰剂对照的临床试验显示，口服镁补充可以改善新发
    MetS，显著降低高血压、高血糖和高三酰甘油血症的发生率（21）。总之，镁在 MetS 的发生和发展中起着重要作用。
- en: Serum magnesium is the most commonly used approach to evaluate magnesium status
    in clinical practice. However, it does not accurately reflect the total-body magnesium
    levels. The serum magnesium level is typically within the normal reference range,
    especially in the case of chronic magnesium deficiency (22, 23). The serum contains
    0.3% of the body's total magnesium, and the rest is primarily stored in bones,
    muscles, and soft tissue (24). Both urinary magnesium levels and the fractional
    excretion of magnesium (FEMg) serve as methods for assessing magnesium status.
    The FEMg is calculated using the concentrations of magnesium and creatinine both
    in serum and urine, and can serve as a useful tool in assessing magnesium status
    (25). However, both urinary magnesium and FEMg are easily influenced by various
    factors such as renal function and dietary intake (26). The magnesium tolerance
    test is regarded as a gold standard for evaluating the magnesium status of the
    body, but it is impractical and difficult to apply broadly since it requires a
    first 24-hour urine collection, intravenous magnesium infusion, and then a second
    24-hour urine collection (27, 28). The oral magnesium loading test is another
    method for assessing magnesium deficiency. This noninvasive procedure merely requires
    the oral intake of magnesium and urine collection. However, it necessitates the
    collection of urine over a specific duration, typically 24 hours, which can pose
    an inconvenience for the patient. This factor may restrict its utilization in
    routine clinical practice (29). Although intense research activities have been
    dedicated to magnesium, the difficulties of accessing total-body magnesium, and
    its main 2 compartments, namely bone and muscle, mean that today there is still
    no simple, rapid, and accurate laboratory test to indicate total-body magnesium
    status in humans (28). The MDS has been demonstrated as a good indicator for predicting
    magnesium deficiency validated by a magnesium tolerance test (12). It is a simple
    and easy tool to evaluate magnesium deficiency. This implies that the incorporation
    of MDS with other methods for assessing magnesium status could potentially enhance
    our ability to effectively identify individuals with magnesium deficiency.
  id: totrans-split-605
  prefs: []
  type: TYPE_NORMAL
  zh: 血清镁是临床实践中评估镁状态最常用的方法。然而，它并不能准确反映全身镁水平。血清镁水平通常在正常参考范围内，尤其是在慢性镁缺乏的情况下（22, 23）。血清包含身体总镁量的0.3%，其余主要储存在骨骼、肌肉和软组织中（24）。尿镁水平和镁的分数排泄率（FEMg）均作为评估镁状态的方法。FEMg是通过血清和尿液中镁和肌酐的浓度计算得出的，可以作为评估镁状态的有用工具（25）。然而，尿镁和FEMg都易受肾功能和饮食摄入等各种因素的影响（26）。镁耐量试验被认为是评估体内镁状态的金标准，但由于需要首先进行24小时尿液收集、静脉注射镁、然后进行第二次24小时尿液收集，因此在广泛应用上并不实际且难以执行（27,
    28）。口服镁负荷试验是另一种评估镁缺乏的方法。这种无创检查过程仅需口服镁并收集尿液。然而，它需要在特定时间段内，通常是24小时内收集尿液，这可能对患者造成不便。这一因素可能限制其在常规临床实践中的使用（29）。尽管已经有大量研究致力于镁的研究，但难以访问全身镁及其主要两个部位（骨骼和肌肉）的困难意味着今天仍然没有简单、快速和准确的实验室检测方法来指示人类全身镁状态（28）。MDS已被证明是预测镁缺乏的良好指标，经镁耐量试验验证（12）。它是评估镁缺乏的简单易用工具。这意味着将MDS与其他评估镁状态的方法结合，有可能增强我们有效识别镁缺乏个体的能力。
- en: The MDS combines 4 risk factors affecting magnesium reabsorption in the US population,
    including alcohol consumption, diuretics, PPI, and kidney function (12). For instance,
    alcohol consumption causes a prompt increase in the urinary excretion of magnesium
    (30). Similarly, diuretics can enhance magnesium excretion (31). The administration
    of a PPI has been shown to reduce kidney reabsorption of magnesium by downregulating
    TRPM6 activity (32). In addition to alcohol and medication use, magnesium reabsorption
    in the kidney can be drastically altered under certain pathophysiological conditions.
    Chronic kidney disease is accompanied by increased renal magnesium-wasting (33)
    and, thus, impaired kidney function has been recognized as an essential pathway
    underlying magnesium depletion from the urine. Overall, these factors contribute
    to the utility of MDS as a comprehensive measurement tool for evaluating the status
    of magnesium.
  id: totrans-split-606
  prefs: []
  type: TYPE_NORMAL
  zh: MDS结合了影响美国人群镁重吸收的4个危险因素，包括饮酒、利尿剂、质子泵抑制剂（PPI）和肾功能（12）。例如，饮酒会迅速增加尿镁排泄（30）。类似地，利尿剂可以增加镁的排泄（31）。据显示，PPI的使用通过下调TRPM6活性减少了肾脏对镁的重吸收（32）。除了饮酒和药物使用外，某些病理生理条件下肾脏对镁的重吸收也可能发生显著改变。慢性肾病伴随肾性镁浪费增加（33），因此，肾功能受损已被公认为镁从尿液中排出的重要途径。总体来看，这些因素共同促进了MDS作为评估镁状态的综合测量工具的实用性。
- en: To our knowledge, there have been no studies investigating the association between
    magnesium deficiency, assessed using an easy-to-use tool like the MDS, and MetS.
  id: totrans-split-607
  prefs: []
  type: TYPE_NORMAL
  zh: 据我们所知，还没有研究调查使用像MDS这样易于使用的工具评估的镁缺乏与MetS之间的关联。
- en: In this study, we discovered a positive association between the MDS, a newly
    developed assessment metric for magnesium status, and MetS. Our findings are supported
    by some clinical research. A systematic review and meta-analysis evaluated the
    theory that a higher magnesium intake is associated with a lower risk of MetS
    (9 articles, n = 31 876, OR = 0.73; 95% CI, 0.62-0.86; *P* < .001) (34). Other
    evidence suggests that dietary magnesium has beneficial effects, including regulating
    systemic inflammation (35) and hypertension (36), regulating lipids (37), glucose
    and insulin metabolism, improving insulin sensitivity (38), and reducing the risk
    of diabetes (39). However, data regarding the association between magnesium status
    and MetS are conflicting. Some studies concluded that serum magnesium levels are
    lower in patients with MetS compared with their controls (40), whereas other studies
    reported a nonsignificant association (41) or even proposed that there may be
    a positive association between serum magnesium concentration and MetS (42). In
    hypertension, a similar situation exists. A systematic review and meta-analysis
    of prospective cohort studies found an inverse association between dietary magnesium
    intake and the risk of hypertension comparing the highest intake group with the
    lowest. However, the association of serum magnesium concentration with the risk
    of hypertension was marginally significant (36). This may be because serum magnesium
    cannot reflect the actual status of whole-body magnesium levels. Therefore, it
    is very important to find an indicator of the supplement of serum magnesium, to
    better reflect the status of magnesium levels in the body.
  id: totrans-split-608
  prefs: []
  type: TYPE_NORMAL
  zh: 在本研究中，我们发现了MDS（一种新开发的镁状态评估指标）与MetS之间存在正向关联。我们的发现得到了一些临床研究的支持。一项系统回顾和荟萃分析评估了镁摄入量较高与MetS风险较低之间的理论（9篇文章，n
    = 31,876，OR = 0.73；95% CI，0.62-0.86；*P* < .001）（34）。其他证据表明，膳食镁具有诸多益处，包括调节全身炎症（35）、高血压（36）、调节脂质（37）、葡萄糖和胰岛素代谢，改善胰岛素敏感性（38），以及降低糖尿病风险（39）。然而，关于镁状态与MetS之间的关联数据存在争议。一些研究得出结论，与其对照组相比，MetS患者的血清镁水平较低（40），而其他研究则报告了无显著关联（41），甚至提出血清镁浓度与MetS可能存在正向关联（42）。在高血压方面也存在类似情况。一项前瞻性队列研究的系统回顾和荟萃分析发现，膳食镁摄入与高血压风险之间存在反向关联，比较最高摄入组与最低摄入组。然而，血清镁浓度与高血压风险的关联则略显显著（36）。这可能是因为血清镁不能反映全身镁水平的实际状态。因此，寻找补充血清镁的指标以更好地反映体内镁水平的状态非常重要。
- en: This study sheds light on the issue of magnesium deficiency and uncovers a positive
    correlation between MDS and the risk of MetS. The results imply that we need to
    be vigilant about MetS risk, especially for patients with a higher MDS. This allows
    us to identify individuals in the community who may be in a magnesium-deficient
    state through the use of MDS and other assessment methods, and provide magnesium
    supplementation to these populations to reduce the incidence of MetS.
  id: totrans-split-609
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究揭示了镁缺乏问题，并揭示了MDS与MetS风险之间的正相关。结果表明，我们需要对MetS风险保持警惕，特别是对于MDS较高的患者。这使我们能够通过MDS和其他评估方法识别社区中可能处于镁缺乏状态的个体，并为这些人群提供镁补充剂，以降低MetS的发生率。
- en: Our study has several advantages. This is the first large, national study to
    investigate the association between MDS and MetS based on the well-designed NHNAES
    data. It is worth noting that the analysis incorporates the use of sampling weights
    assigned to each participant. These weights play a crucial role in enabling statistical
    inferences and generalizing our findings to a larger population beyond the sample
    size of MetS cases. By accounting for these weights, our study ensures reliable
    conclusions and precise statistical power. In addition, a stratified subgroup
    analysis was conducted to further investigate the relationship between MDS and
    MetS across different population groups, which suggests that we need to implement
    more precise prevention strategies for MetS. Furthermore, MDS rather than serum
    magnesium was used in our study, which is more reflective of the physiological
    state of magnesium.
  id: totrans-split-610
  prefs: []
  type: TYPE_NORMAL
  zh: 我们的研究具有几个优点。这是第一个基于精心设计的NHANES数据，探讨MDS与MetS之间关联的大型全国性研究。值得注意的是，该分析包括为每个参与者分配的抽样权重的使用。这些权重在实现统计推断并将我们的发现推广到MetS病例样本大小之外的更大人群方面发挥了关键作用。通过考虑这些权重，我们的研究确保了可靠的结论和精确的统计能力。此外，还进行了分层亚组分析，进一步探讨了MDS在不同人群中与MetS之间的关系，这表明我们需要实施更精确的MetS预防策略。此外，我们的研究中使用的是MDS而不是血清镁，后者更能反映镁的生理状态。
- en: This study also has some limitations that need to be clarified. First, we observed
    that there is a nonsignificant association between MDS and Mets when MDS = 5\.
    This may be attributable to the small number of participants with MDS = 5, which
    totaled only 6 individuals. Second, we did not evaluate whether MDS was a “better”
    indicator of magnesium deficiency compared to serum magnesium levels because of
    the lack of serum magnesium in NHANES. Furthermore, the cross-sectional study
    design cannot definitively determine causation between MDS and MetS. It is also
    worth noting that MDS is a categorical variable, not a continuous variable. In
    addition, while MDS includes PPI and diuretics, other drugs such as tetracyclines,
    bisphosphonates, β-adrenergic agonists, insulin, etc, which can affect magnesium
    levels (31), are not accounted for in MDS. Last, although several covariates were
    adjusted to investigate the association between MDS and MetS, potential confounders
    that might have effects on the results were not included.
  id: totrans-split-611
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，这项研究还存在一些需要澄清的限制。首先，当MDS = 5时，我们观察到MDS与MetS之间的非显著关联。这可能归因于MDS = 5的参与者数量较少，仅有6人。其次，由于NHANES中缺乏血清镁，我们未评估MDS是否比血清镁更好地指示镁缺乏。此外，横断面研究设计不能确定MDS与MetS之间的因果关系。还值得注意的是，MDS是一个分类变量，而不是连续变量。此外，尽管MDS包括PPI和利尿剂，但未考虑到其他药物如四环素类、双磷酸盐、β肾上腺素激动剂、胰岛素等可能影响镁水平的药物（31）。最后，虽然我们调整了几个混杂变量以调查MDS与MetS之间的关联，但未包括可能对结果产生影响的潜在混杂因素。
- en: In conclusion, our study identified a significant association between MDS and
    MetS, and further explored differences across various subgroups. In addition to
    having major implications for clinical practice, our findings have important public
    health implications as well. It is possible to prevent and reduce MetS by supplementing
    with magnesium supplements or encouraging higher magnesium intake diet because
    diet is a factor that can be changed.
  id: totrans-split-612
  prefs: []
  type: TYPE_NORMAL
  zh: 总之，我们的研究确定了MDS与MetS之间的显著关联，并进一步探讨了不同亚组之间的差异。除了对临床实践有重大影响外，我们的发现还对公共卫生有重要影响。通过补充镁剂或鼓励摄入更多镁的饮食，可以预防和减少MetS，因为饮食是可以改变的因素。
- en: Acknowledgments
  id: totrans-split-613
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 致谢
- en: The author thanks the staff and the participants of the NHANES study for their
    valuable contributions.
  id: totrans-split-614
  prefs: []
  type: TYPE_NORMAL
  zh: 作者感谢NHANES研究的工作人员和参与者对其宝贵贡献。
- en: Funding
  id: totrans-split-615
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 资助
- en: This work was supported by the National Natural Science Foundation of China
    (grant Nos. 82371572 and 82170842 to Zhen Liang and No. 82171556 to Lin Kang)
    and the Natural Science Foundation of Shenzhen Municipality (No. KCXFZ20201221173600001
    to Zhen Liang).
  id: totrans-split-616
  prefs: []
  type: TYPE_NORMAL
  zh: 本研究得到了国家自然科学基金（资助号82371572和82170842，资助人：梁振，资助号82171556，资助人：康林）和深圳市自然科学基金（资助号KCXFZ20201221173600001，资助人：梁振）的支持。
- en: Disclosures
  id: totrans-split-617
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 披露
- en: All contributing authors have approved the final manuscript version and report
    no conflicts of interest.
  id: totrans-split-618
  prefs: []
  type: TYPE_NORMAL
  zh: 所有贡献作者已批准最终稿，并报告无利益冲突。
- en: Data Availability
  id: totrans-split-619
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 数据可用性
- en: Publicly available data sets were analyzed in this study. These data can be
    found at [https://www.cdc.gov/nchs/nhanes/index.htm](https://www.cdc.gov/nchs/nhanes/index.htm).
  id: totrans-split-620
  prefs: []
  type: TYPE_NORMAL
  zh: 公共可用数据集在本研究中进行了分析。这些数据可以在 [https://www.cdc.gov/nchs/nhanes/index.htm](https://www.cdc.gov/nchs/nhanes/index.htm)
    找到。
- en: References
  id: totrans-split-621
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 参考文献
- en: '1'
  id: totrans-split-622
  prefs: []
  type: TYPE_NORMAL
  zh: '1'
- en: Eckel
  id: totrans-split-623
  prefs: []
  type: TYPE_NORMAL
  zh: Eckel
- en: RH
  id: totrans-split-624
  prefs: []
  type: TYPE_NORMAL
  zh: RH
- en: ', Grundy'
  id: totrans-split-625
  prefs: []
  type: TYPE_NORMAL
  zh: ', Grundy'
- en: SM , Zimmet
  id: totrans-split-626
  prefs: []
  type: TYPE_NORMAL
  zh: SM , Zimmet
- en: PZ .
  id: totrans-split-627
  prefs: []
  type: TYPE_NORMAL
  zh: PZ .
- en: The metabolic syndrome
  id: totrans-split-628
  prefs: []
  type: TYPE_NORMAL
  zh: 新陈代谢综合征
- en: .
  id: totrans-split-629
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Lancet
  id: totrans-split-630
  prefs: []
  type: TYPE_NORMAL
  zh: 兰塞特
- en: .
  id: totrans-split-631
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2005'
  id: totrans-split-632
  prefs: []
  type: TYPE_NORMAL
  zh: '2005'
- en: ;
  id: totrans-split-633
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '365'
  id: totrans-split-634
  prefs: []
  type: TYPE_NORMAL
  zh: '365'
- en: (
  id: totrans-split-635
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '9468'
  id: totrans-split-636
  prefs: []
  type: TYPE_NORMAL
  zh: '9468'
- en: '):'
  id: totrans-split-637
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '1415'
  id: totrans-split-638
  prefs: []
  type: TYPE_NORMAL
  zh: '1415'
- en: ‐
  id: totrans-split-639
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '1428'
  id: totrans-split-640
  prefs: []
  type: TYPE_NORMAL
  zh: '1428'
- en: .
  id: totrans-split-641
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2'
  id: totrans-split-642
  prefs: []
  type: TYPE_NORMAL
  zh: '2'
- en: Lebovitz
  id: totrans-split-643
  prefs: []
  type: TYPE_NORMAL
  zh: Lebovitz
- en: HE
  id: totrans-split-644
  prefs: []
  type: TYPE_NORMAL
  zh: HE
- en: .
  id: totrans-split-645
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: 'Insulin resistance: definition and consequences'
  id: totrans-split-646
  prefs: []
  type: TYPE_NORMAL
  zh: 胰岛素抵抗：定义和后果
- en: .
  id: totrans-split-647
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Exp Clin Endocrinol Diabetes
  id: totrans-split-648
  prefs: []
  type: TYPE_NORMAL
  zh: 实验与临床内分泌学与糖尿病
- en: .
  id: totrans-split-649
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2001'
  id: totrans-split-650
  prefs: []
  type: TYPE_NORMAL
  zh: '2001'
- en: ;
  id: totrans-split-651
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '109'
  id: totrans-split-652
  prefs: []
  type: TYPE_NORMAL
  zh: '109'
- en: (
  id: totrans-split-653
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: Suppl 2
  id: totrans-split-654
  prefs: []
  type: TYPE_NORMAL
  zh: 补充2
- en: '):'
  id: totrans-split-655
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: S135
  id: totrans-split-656
  prefs: []
  type: TYPE_NORMAL
  zh: S135
- en: ‐
  id: totrans-split-657
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: S148
  id: totrans-split-658
  prefs: []
  type: TYPE_NORMAL
  zh: S148
- en: .
  id: totrans-split-659
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '3'
  id: totrans-split-660
  prefs: []
  type: TYPE_NORMAL
  zh: '3'
- en: Haffner
  id: totrans-split-661
  prefs: []
  type: TYPE_NORMAL
  zh: 哈弗纳
- en: SM
  id: totrans-split-662
  prefs: []
  type: TYPE_NORMAL
  zh: SM
- en: ', Valdez'
  id: totrans-split-663
  prefs: []
  type: TYPE_NORMAL
  zh: ', Valdez'
- en: RA , Hazuda
  id: totrans-split-664
  prefs: []
  type: TYPE_NORMAL
  zh: RA , Hazuda
- en: HP , Mitchell
  id: totrans-split-665
  prefs: []
  type: TYPE_NORMAL
  zh: HP , Mitchell
- en: BD , Morales
  id: totrans-split-666
  prefs: []
  type: TYPE_NORMAL
  zh: BD , Morales
- en: PA , Stern
  id: totrans-split-667
  prefs: []
  type: TYPE_NORMAL
  zh: PA , Stern
- en: MP .
  id: totrans-split-668
  prefs: []
  type: TYPE_NORMAL
  zh: MP .
- en: Prospective analysis of the insulin-resistance syndrome (syndrome X)
  id: totrans-split-669
  prefs: []
  type: TYPE_NORMAL
  zh: 胰岛素抵抗综合征（综合征X）前瞻性分析
- en: .
  id: totrans-split-670
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Diabetes
  id: totrans-split-671
  prefs: []
  type: TYPE_NORMAL
  zh: 糖尿病
- en: .
  id: totrans-split-672
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '1992'
  id: totrans-split-673
  prefs: []
  type: TYPE_NORMAL
  zh: '1992'
- en: ;
  id: totrans-split-674
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '41'
  id: totrans-split-675
  prefs: []
  type: TYPE_NORMAL
  zh: '41'
- en: (
  id: totrans-split-676
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '6'
  id: totrans-split-677
  prefs: []
  type: TYPE_NORMAL
  zh: '6'
- en: '):'
  id: totrans-split-678
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '715'
  id: totrans-split-679
  prefs: []
  type: TYPE_NORMAL
  zh: '715'
- en: ‐
  id: totrans-split-680
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '722'
  id: totrans-split-681
  prefs: []
  type: TYPE_NORMAL
  zh: '722'
- en: .
  id: totrans-split-682
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '4'
  id: totrans-split-683
  prefs: []
  type: TYPE_NORMAL
  zh: '4'
- en: Alberti
  id: totrans-split-684
  prefs: []
  type: TYPE_NORMAL
  zh: Alberti
- en: KGMM
  id: totrans-split-685
  prefs: []
  type: TYPE_NORMAL
  zh: KGMM
- en: ', Zimmet'
  id: totrans-split-686
  prefs: []
  type: TYPE_NORMAL
  zh: ', Zimmet'
- en: PZ .
  id: totrans-split-687
  prefs: []
  type: TYPE_NORMAL
  zh: PZ .
- en: 'Definition, diagnosis and classification of diabetes mellitus and its complications.
    Part 1: diagnosis and classification of diabetes mellitus provisional report of
    a WHO consultation'
  id: totrans-split-688
  prefs: []
  type: TYPE_NORMAL
  zh: 糖尿病及其并发症的定义、诊断和分类。第一部分：糖尿病的诊断和分类，世卫组织咨询会议临时报告
- en: .
  id: totrans-split-689
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Diabet Med
  id: totrans-split-690
  prefs: []
  type: TYPE_NORMAL
  zh: 糖尿病医学
- en: .
  id: totrans-split-691
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '1998'
  id: totrans-split-692
  prefs: []
  type: TYPE_NORMAL
  zh: '1998'
- en: ;
  id: totrans-split-693
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '15'
  id: totrans-split-694
  prefs: []
  type: TYPE_NORMAL
  zh: '15'
- en: (
  id: totrans-split-695
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '7'
  id: totrans-split-696
  prefs: []
  type: TYPE_NORMAL
  zh: '7'
- en: '):'
  id: totrans-split-697
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '539'
  id: totrans-split-698
  prefs: []
  type: TYPE_NORMAL
  zh: '539'
- en: ‐
  id: totrans-split-699
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '553'
  id: totrans-split-700
  prefs: []
  type: TYPE_NORMAL
  zh: '553'
- en: .
  id: totrans-split-701
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '5'
  id: totrans-split-702
  prefs: []
  type: TYPE_NORMAL
  zh: '5'
- en: Grundy
  id: totrans-split-703
  prefs: []
  type: TYPE_NORMAL
  zh: Grundy
- en: SM
  id: totrans-split-704
  prefs: []
  type: TYPE_NORMAL
  zh: SM
- en: ', Brewer'
  id: totrans-split-705
  prefs: []
  type: TYPE_NORMAL
  zh: ', Brewer'
- en: HB
  id: totrans-split-706
  prefs: []
  type: TYPE_NORMAL
  zh: HB
- en: Jr, Cleeman
  id: totrans-split-707
  prefs: []
  type: TYPE_NORMAL
  zh: Jr, Cleeman
- en: JI , Smith
  id: totrans-split-708
  prefs: []
  type: TYPE_NORMAL
  zh: JI , Smith
- en: SC
  id: totrans-split-709
  prefs: []
  type: TYPE_NORMAL
  zh: SC
- en: Jr, Lenfant
  id: totrans-split-710
  prefs: []
  type: TYPE_NORMAL
  zh: Jr, Lenfant
- en: C .
  id: totrans-split-711
  prefs: []
  type: TYPE_NORMAL
  zh: C .
- en: 'Definition of metabolic syndrome: report of the National Heart, Lung, and Blood
    Institute/American Heart Association conference on scientific issues related to
    definition'
  id: totrans-split-712
  prefs: []
  type: TYPE_NORMAL
  zh: 新陈代谢综合征的定义：国家心肺血液研究所/美国心脏协会关于定义相关科学问题的会议报告
- en: .
  id: totrans-split-713
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Circulation
  id: totrans-split-714
  prefs: []
  type: TYPE_NORMAL
  zh: 循环
- en: .
  id: totrans-split-715
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2004'
  id: totrans-split-716
  prefs: []
  type: TYPE_NORMAL
  zh: '2004'
- en: ;
  id: totrans-split-717
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '109'
  id: totrans-split-718
  prefs: []
  type: TYPE_NORMAL
  zh: '109'
- en: (
  id: totrans-split-719
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '3'
  id: totrans-split-720
  prefs: []
  type: TYPE_NORMAL
  zh: '3'
- en: '):'
  id: totrans-split-721
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '433'
  id: totrans-split-722
  prefs: []
  type: TYPE_NORMAL
  zh: '433'
- en: ‐
  id: totrans-split-723
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '438'
  id: totrans-split-724
  prefs: []
  type: TYPE_NORMAL
  zh: '438'
- en: .
  id: totrans-split-725
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '6'
  id: totrans-split-726
  prefs: []
  type: TYPE_NORMAL
  zh: '6'
- en: Tangvoraphonkchai
  id: totrans-split-727
  prefs: []
  type: TYPE_NORMAL
  zh: Tangvoraphonkchai
- en: K
  id: totrans-split-728
  prefs: []
  type: TYPE_NORMAL
  zh: K
- en: ', Davenport'
  id: totrans-split-729
  prefs: []
  type: TYPE_NORMAL
  zh: ', Davenport'
- en: A .
  id: totrans-split-730
  prefs: []
  type: TYPE_NORMAL
  zh: A .
- en: Magnesium and cardiovascular disease
  id: totrans-split-731
  prefs: []
  type: TYPE_NORMAL
  zh: 镁与心血管疾病
- en: .
  id: totrans-split-732
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Adv Chronic Kidney Dis
  id: totrans-split-733
  prefs: []
  type: TYPE_NORMAL
  zh: 慢性肾脏病进展
- en: .
  id: totrans-split-734
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2018'
  id: totrans-split-735
  prefs: []
  type: TYPE_NORMAL
  zh: '2018'
- en: ;
  id: totrans-split-736
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '25'
  id: totrans-split-737
  prefs: []
  type: TYPE_NORMAL
  zh: '25'
- en: (
  id: totrans-split-738
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '3'
  id: totrans-split-739
  prefs: []
  type: TYPE_NORMAL
  zh: '3'
- en: '):'
  id: totrans-split-740
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '251'
  id: totrans-split-741
  prefs: []
  type: TYPE_NORMAL
  zh: '251'
- en: ‐
  id: totrans-split-742
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '260'
  id: totrans-split-743
  prefs: []
  type: TYPE_NORMAL
  zh: '260'
- en: .
  id: totrans-split-744
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '7'
  id: totrans-split-745
  prefs: []
  type: TYPE_NORMAL
  zh: '7'
- en: Pickering
  id: totrans-split-746
  prefs: []
  type: TYPE_NORMAL
  zh: Pickering
- en: G
  id: totrans-split-747
  prefs: []
  type: TYPE_NORMAL
  zh: G
- en: ', Mazur'
  id: totrans-split-748
  prefs: []
  type: TYPE_NORMAL
  zh: ', Mazur'
- en: A , Trousselard
  id: totrans-split-749
  prefs: []
  type: TYPE_NORMAL
  zh: A , Trousselard
- en: M , et al.
  id: totrans-split-750
  prefs: []
  type: TYPE_NORMAL
  zh: M , 等人。
- en: 'Magnesium status and stress: the vicious circle concept revisited'
  id: totrans-split-751
  prefs: []
  type: TYPE_NORMAL
  zh: 镁状态与压力：重新审视恶性循环概念
- en: .
  id: totrans-split-752
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Nutrients
  id: totrans-split-753
  prefs: []
  type: TYPE_NORMAL
  zh: 营养素
- en: .
  id: totrans-split-754
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2020'
  id: totrans-split-755
  prefs: []
  type: TYPE_NORMAL
  zh: '2020'
- en: ;
  id: totrans-split-756
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '12'
  id: totrans-split-757
  prefs: []
  type: TYPE_NORMAL
  zh: '12'
- en: (
  id: totrans-split-758
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '12'
  id: totrans-split-759
  prefs: []
  type: TYPE_NORMAL
  zh: '12'
- en: '):'
  id: totrans-split-760
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '3672'
  id: totrans-split-761
  prefs: []
  type: TYPE_NORMAL
  zh: '3672'
- en: .
  id: totrans-split-762
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '8'
  id: totrans-split-763
  prefs: []
  type: TYPE_NORMAL
  zh: '8'
- en: Tarleton
  id: totrans-split-764
  prefs: []
  type: TYPE_NORMAL
  zh: Tarleton
- en: EK
  id: totrans-split-765
  prefs: []
  type: TYPE_NORMAL
  zh: EK
- en: .
  id: totrans-split-766
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Factors influencing magnesium consumption among adults in the United States
  id: totrans-split-767
  prefs: []
  type: TYPE_NORMAL
  zh: 美国成年人镁摄入量影响因素
- en: .
  id: totrans-split-768
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Nutr Rev
  id: totrans-split-769
  prefs: []
  type: TYPE_NORMAL
  zh: 营养评论
- en: .
  id: totrans-split-770
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2018'
  id: totrans-split-771
  prefs: []
  type: TYPE_NORMAL
  zh: '2018'
- en: ;
  id: totrans-split-772
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '76'
  id: totrans-split-773
  prefs: []
  type: TYPE_NORMAL
  zh: '76'
- en: (
  id: totrans-split-774
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '7'
  id: totrans-split-775
  prefs: []
  type: TYPE_NORMAL
  zh: '7'
- en: '):'
  id: totrans-split-776
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '526'
  id: totrans-split-777
  prefs: []
  type: TYPE_NORMAL
  zh: '526'
- en: ‐
  id: totrans-split-778
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '538'
  id: totrans-split-779
  prefs: []
  type: TYPE_NORMAL
  zh: '538'
- en: .
  id: totrans-split-780
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '9'
  id: totrans-split-781
  prefs: []
  type: TYPE_NORMAL
  zh: '9'
- en: Wu
  id: totrans-split-782
  prefs: []
  type: TYPE_NORMAL
  zh: 吴
- en: J
  id: totrans-split-783
  prefs: []
  type: TYPE_NORMAL
  zh: J
- en: ', Xun'
  id: totrans-split-784
  prefs: []
  type: TYPE_NORMAL
  zh: ', Xun'
- en: P , Tang
  id: totrans-split-785
  prefs: []
  type: TYPE_NORMAL
  zh: P , Tang
- en: Q , Cai
  id: totrans-split-786
  prefs: []
  type: TYPE_NORMAL
  zh: Q , Cai
- en: W , He
  id: totrans-split-787
  prefs: []
  type: TYPE_NORMAL
  zh: W , He
- en: K .
  id: totrans-split-788
  prefs: []
  type: TYPE_NORMAL
  zh: K .
- en: 'Circulating magnesium levels and incidence of coronary heart diseases, hypertension,
    and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies'
  id: totrans-split-789
  prefs: []
  type: TYPE_NORMAL
  zh: 血清镁水平与冠心病、高血压和2型糖尿病发生率：前瞻性队列研究的荟萃分析
- en: .
  id: totrans-split-790
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Nutr J
  id: totrans-split-791
  prefs: []
  type: TYPE_NORMAL
  zh: 营养学杂志
- en: .
  id: totrans-split-792
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2017'
  id: totrans-split-793
  prefs: []
  type: TYPE_NORMAL
  zh: '2017'
- en: ;
  id: totrans-split-794
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '16'
  id: totrans-split-795
  prefs: []
  type: TYPE_NORMAL
  zh: '16'
- en: (
  id: totrans-split-796
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '1'
  id: totrans-split-797
  prefs: []
  type: TYPE_NORMAL
  zh: '1'
- en: '):'
  id: totrans-split-798
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '60'
  id: totrans-split-799
  prefs: []
  type: TYPE_NORMAL
  zh: '60'
- en: .
  id: totrans-split-800
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '10'
  id: totrans-split-801
  prefs: []
  type: TYPE_NORMAL
  zh: '10'
- en: Oost
  id: totrans-split-802
  prefs: []
  type: TYPE_NORMAL
  zh: Oost
- en: LJ
  id: totrans-split-803
  prefs: []
  type: TYPE_NORMAL
  zh: LJ
- en: ', Tack'
  id: totrans-split-804
  prefs: []
  type: TYPE_NORMAL
  zh: ', Tack'
- en: CJ , de Baaij
  id: totrans-split-805
  prefs: []
  type: TYPE_NORMAL
  zh: CJ , de Baaij
- en: JHF .
  id: totrans-split-806
  prefs: []
  type: TYPE_NORMAL
  zh: JHF .
- en: Hypomagnesemia and cardiovascular risk in type 2 diabetes
  id: totrans-split-807
  prefs: []
  type: TYPE_NORMAL
  zh: 低镁血症与2型糖尿病的心血管风险
- en: .
  id: totrans-split-808
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Endocr Rev
  id: totrans-split-809
  prefs: []
  type: TYPE_NORMAL
  zh: 内分泌学评论
- en: .
  id: totrans-split-810
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2023'
  id: totrans-split-811
  prefs: []
  type: TYPE_NORMAL
  zh: '2023'
- en: ;
  id: totrans-split-812
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '44'
  id: totrans-split-813
  prefs: []
  type: TYPE_NORMAL
  zh: '44'
- en: (
  id: totrans-split-814
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '3'
  id: totrans-split-815
  prefs: []
  type: TYPE_NORMAL
  zh: '3'
- en: '):'
  id: totrans-split-816
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '357'
  id: totrans-split-817
  prefs: []
  type: TYPE_NORMAL
  zh: '357'
- en: ‐
  id: totrans-split-818
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '378'
  id: totrans-split-819
  prefs: []
  type: TYPE_NORMAL
  zh: '378'
- en: .
  id: totrans-split-820
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '11'
  id: totrans-split-821
  prefs: []
  type: TYPE_NORMAL
  zh: '11'
- en: Xing
  id: totrans-split-822
  prefs: []
  type: TYPE_NORMAL
  zh: 邢
- en: B
  id: totrans-split-823
  prefs: []
  type: TYPE_NORMAL
  zh: B
- en: ', Xu'
  id: totrans-split-824
  prefs: []
  type: TYPE_NORMAL
  zh: ', Xu'
- en: X , Li
  id: totrans-split-825
  prefs: []
  type: TYPE_NORMAL
  zh: X , Li
- en: C , Zhao
  id: totrans-split-826
  prefs: []
  type: TYPE_NORMAL
  zh: C , Zhao
- en: Y , Wang
  id: totrans-split-827
  prefs: []
  type: TYPE_NORMAL
  zh: Y , Wang
- en: Y , Zhao
  id: totrans-split-828
  prefs: []
  type: TYPE_NORMAL
  zh: Y , Zhao
- en: W .
  id: totrans-split-829
  prefs: []
  type: TYPE_NORMAL
  zh: W .
- en: 'Reduced serum magnesium levels are associated with the occurrence of retinopathy
    in patients with type 2 diabetes mellitus: a retrospective study'
  id: totrans-split-830
  prefs: []
  type: TYPE_NORMAL
  zh: 血清镁水平降低与2型糖尿病患者视网膜病变的发生相关：一项回顾性研究
- en: .
  id: totrans-split-831
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Biol Trace Elem Res
  id: totrans-split-832
  prefs: []
  type: TYPE_NORMAL
  zh: 生物微量元素研究
- en: .
  id: totrans-split-833
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2022'
  id: totrans-split-834
  prefs: []
  type: TYPE_NORMAL
  zh: '2022'
- en: ;
  id: totrans-split-835
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '200'
  id: totrans-split-836
  prefs: []
  type: TYPE_NORMAL
  zh: '200'
- en: (
  id: totrans-split-837
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '5'
  id: totrans-split-838
  prefs: []
  type: TYPE_NORMAL
  zh: '5'
- en: '):'
  id: totrans-split-839
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '2025'
  id: totrans-split-840
  prefs: []
  type: TYPE_NORMAL
  zh: '2025'
- en: ‐
  id: totrans-split-841
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '2032'
  id: totrans-split-842
  prefs: []
  type: TYPE_NORMAL
  zh: '2032'
- en: .
  id: totrans-split-843
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '12'
  id: totrans-split-844
  prefs: []
  type: TYPE_NORMAL
  zh: '12'
- en: Fan
  id: totrans-split-845
  prefs: []
  type: TYPE_NORMAL
  zh: 范
- en: L
  id: totrans-split-846
  prefs: []
  type: TYPE_NORMAL
  zh: L
- en: ', Zhu'
  id: totrans-split-847
  prefs: []
  type: TYPE_NORMAL
  zh: ', Zhu'
- en: X , Rosanoff
  id: totrans-split-848
  prefs: []
  type: TYPE_NORMAL
  zh: X , Rosanoff
- en: A , et al.
  id: totrans-split-849
  prefs: []
  type: TYPE_NORMAL
  zh: A , 等人。
- en: Magnesium depletion score (MDS) predicts risk of systemic inflammation and cardiovascular
    mortality among US adults
  id: totrans-split-850
  prefs: []
  type: TYPE_NORMAL
  zh: 镁缺乏评分（MDS）预测美国成年人系统性炎症和心血管死亡风险
- en: .
  id: totrans-split-851
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: J Nutr
  id: totrans-split-852
  prefs: []
  type: TYPE_NORMAL
  zh: J Nutr
- en: .
  id: totrans-split-853
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '2021'
  id: totrans-split-854
  prefs: []
  type: TYPE_NORMAL
  zh: '2021'
- en: ;
  id: totrans-split-855
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '151'
  id: totrans-split-856
  prefs: []
  type: TYPE_NORMAL
  zh: '151'
- en: (
  id: totrans-split-857
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '8'
  id: totrans-split-858
  prefs: []
  type: TYPE_NORMAL
  zh: '8'
- en: '):'
  id: totrans-split-859
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '2226'
  id: totrans-split-860
  prefs: []
  type: TYPE_NORMAL
  zh: '2226'
- en: ‐
  id: totrans-split-861
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '2235'
  id: totrans-split-862
  prefs: []
  type: TYPE_NORMAL
  zh: '2235'
- en: .
  id: totrans-split-863
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '13'
  id: totrans-split-864
  prefs: []
  type: TYPE_NORMAL
  zh: '13'
- en: Woteki
  id: totrans-split-865
  prefs: []
  type: TYPE_NORMAL
  zh: Woteki
- en: CE
  id: totrans-split-866
  prefs: []
  type: TYPE_NORMAL
  zh: CE
- en: ', Briefel'
  id: totrans-split-867
  prefs: []
  type: TYPE_NORMAL
  zh: ', Briefel'
- en: RR , Kuczmarski
  id: totrans-split-868
  prefs: []
  type: TYPE_NORMAL
  zh: RR , Kuczmarski
- en: R .
  id: totrans-split-869
  prefs: []
  type: TYPE_NORMAL
  zh: R .
- en: Federal monitoring of the nation's nutritional status. Contributions of the
    National Center for Health Statistics
  id: totrans-split-870
  prefs: []
  type: TYPE_NORMAL
  zh: 国家营养状况的联邦监测。国家健康统计中心的贡献
- en: .
  id: totrans-split-871
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: Am J Clin Nutr
  id: totrans-split-872
  prefs: []
  type: TYPE_NORMAL
  zh: 美国临床营养杂志
- en: .
  id: totrans-split-873
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '1988'
  id: totrans-split-874
  prefs: []
  type: TYPE_NORMAL
  zh: '1988'
- en: ;
  id: totrans-split-875
  prefs: []
  type: TYPE_NORMAL
  zh: ;
- en: '47'
  id: totrans-split-876
  prefs: []
  type: TYPE_NORMAL
  zh: '47'
- en: (
  id: totrans-split-877
  prefs: []
  type: TYPE_NORMAL
  zh: (
- en: '2'
  id: totrans-split-878
  prefs: []
  type: TYPE_NORMAL
  zh: '2'
- en: '):'
  id: totrans-split-879
  prefs: []
  type: TYPE_NORMAL
  zh: '):'
- en: '320'
  id: totrans-split-880
  prefs: []
  type: TYPE_NORMAL
  zh: '320'
- en: ‐
  id: totrans-split-881
  prefs: []
  type: TYPE_NORMAL
  zh: ‐
- en: '328'
  id: totrans-split-882
  prefs: []
  type: TYPE_NORMAL
  zh: '328'
- en: .
  id: totrans-split-883
  prefs: []
  type: TYPE_NORMAL
  zh: .
- en: '14'
  id: totrans-split-884
  prefs: []
  type: TYPE_NORMAL
  zh: '14'
- en: Liu
  id: totrans-split-885
  prefs: []
  type: TYPE_NORMAL
- en: H
  id: totrans-split-886
  prefs: []
  type: TYPE_NORMAL
- en: ', Tan'
  id: totrans-split-887
  prefs: []
  type: TYPE_NORMAL
- en: X , Liu
  id: totrans-split-888
  prefs: []
  type: TYPE_NORMAL
- en: Z , et al.
  id: totrans-split-889
  prefs: []
  type: TYPE_NORMAL
- en: 'Association between diet-related inflammation and COPD: findings from NHANES
    III'
  id: totrans-split-890
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-891
  prefs: []
  type: TYPE_NORMAL
- en: Front Nutr
  id: totrans-split-892
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-893
  prefs: []
  type: TYPE_NORMAL
- en: '2021'
  id: totrans-split-894
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-895
  prefs: []
  type: TYPE_NORMAL
- en: '8'
  id: totrans-split-896
  prefs: []
  type: TYPE_NORMAL
- en: ':'
  id: totrans-split-897
  prefs: []
  type: TYPE_NORMAL
- en: '732099'
  id: totrans-split-898
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-899
  prefs: []
  type: TYPE_NORMAL
- en: '15'
  id: totrans-split-900
  prefs: []
  type: TYPE_NORMAL
- en: Gong
  id: totrans-split-901
  prefs: []
  type: TYPE_NORMAL
- en: R
  id: totrans-split-902
  prefs: []
  type: TYPE_NORMAL
- en: ', Pu'
  id: totrans-split-903
  prefs: []
  type: TYPE_NORMAL
- en: X , Cheng
  id: totrans-split-904
  prefs: []
  type: TYPE_NORMAL
- en: Z , Ding
  id: totrans-split-905
  prefs: []
  type: TYPE_NORMAL
- en: J , Chen
  id: totrans-split-906
  prefs: []
  type: TYPE_NORMAL
- en: Z , Wang
  id: totrans-split-907
  prefs: []
  type: TYPE_NORMAL
- en: Y .
  id: totrans-split-908
  prefs: []
  type: TYPE_NORMAL
- en: 'The association between serum cadmium and diabetes in the general population:
    a cross-sectional study from NHANES (1999–2020)'
  id: totrans-split-909
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-910
  prefs: []
  type: TYPE_NORMAL
- en: Front Nutr
  id: totrans-split-911
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-912
  prefs: []
  type: TYPE_NORMAL
- en: '2022'
  id: totrans-split-913
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-914
  prefs: []
  type: TYPE_NORMAL
- en: '9'
  id: totrans-split-915
  prefs: []
  type: TYPE_NORMAL
- en: ':'
  id: totrans-split-916
  prefs: []
  type: TYPE_NORMAL
- en: '966500'
  id: totrans-split-917
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-918
  prefs: []
  type: TYPE_NORMAL
- en: '16'
  id: totrans-split-919
  prefs: []
  type: TYPE_NORMAL
- en: Levey
  id: totrans-split-920
  prefs: []
  type: TYPE_NORMAL
- en: AS
  id: totrans-split-921
  prefs: []
  type: TYPE_NORMAL
- en: ', Stevens'
  id: totrans-split-922
  prefs: []
  type: TYPE_NORMAL
- en: LA , Schmid
  id: totrans-split-923
  prefs: []
  type: TYPE_NORMAL
- en: CH , et al.
  id: totrans-split-924
  prefs: []
  type: TYPE_NORMAL
- en: A new equation to estimate glomerular filtration rate
  id: totrans-split-925
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-926
  prefs: []
  type: TYPE_NORMAL
- en: Ann Intern Med
  id: totrans-split-927
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-928
  prefs: []
  type: TYPE_NORMAL
- en: '2009'
  id: totrans-split-929
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-930
  prefs: []
  type: TYPE_NORMAL
- en: '150'
  id: totrans-split-931
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-932
  prefs: []
  type: TYPE_NORMAL
- en: '9'
  id: totrans-split-933
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-934
  prefs: []
  type: TYPE_NORMAL
- en: '604'
  id: totrans-split-935
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-936
  prefs: []
  type: TYPE_NORMAL
- en: '612'
  id: totrans-split-937
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-938
  prefs: []
  type: TYPE_NORMAL
- en: '17'
  id: totrans-split-939
  prefs: []
  type: TYPE_NORMAL
- en: Wang
  id: totrans-split-940
  prefs: []
  type: TYPE_NORMAL
- en: Q
  id: totrans-split-941
  prefs: []
  type: TYPE_NORMAL
- en: ', Oliver-Williams'
  id: totrans-split-942
  prefs: []
  type: TYPE_NORMAL
- en: C , Raitakari
  id: totrans-split-943
  prefs: []
  type: TYPE_NORMAL
- en: OT , et al.
  id: totrans-split-944
  prefs: []
  type: TYPE_NORMAL
- en: 'Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target
    Mendelian randomization analysis'
  id: totrans-split-945
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-946
  prefs: []
  type: TYPE_NORMAL
- en: Eur Heart J
  id: totrans-split-947
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-948
  prefs: []
  type: TYPE_NORMAL
- en: '2021'
  id: totrans-split-949
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-950
  prefs: []
  type: TYPE_NORMAL
- en: '42'
  id: totrans-split-951
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-952
  prefs: []
  type: TYPE_NORMAL
- en: '12'
  id: totrans-split-953
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-954
  prefs: []
  type: TYPE_NORMAL
- en: '1160'
  id: totrans-split-955
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-956
  prefs: []
  type: TYPE_NORMAL
- en: '1169'
  id: totrans-split-957
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-958
  prefs: []
  type: TYPE_NORMAL
- en: '18'
  id: totrans-split-959
  prefs: []
  type: TYPE_NORMAL
- en: Fang
  id: totrans-split-960
  prefs: []
  type: TYPE_NORMAL
- en: X
  id: totrans-split-961
  prefs: []
  type: TYPE_NORMAL
- en: ', Wang'
  id: totrans-split-962
  prefs: []
  type: TYPE_NORMAL
- en: K , Han
  id: totrans-split-963
  prefs: []
  type: TYPE_NORMAL
- en: D , et al.
  id: totrans-split-964
  prefs: []
  type: TYPE_NORMAL
- en: 'Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes,
    and all-cause mortality: a dose-response meta-analysis of prospective cohort studies'
  id: totrans-split-965
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-966
  prefs: []
  type: TYPE_NORMAL
- en: BMC Med
  id: totrans-split-967
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-968
  prefs: []
  type: TYPE_NORMAL
- en: '2016'
  id: totrans-split-969
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-970
  prefs: []
  type: TYPE_NORMAL
- en: '14'
  id: totrans-split-971
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-972
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-973
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-974
  prefs: []
  type: TYPE_NORMAL
- en: '210'
  id: totrans-split-975
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-976
  prefs: []
  type: TYPE_NORMAL
- en: '19'
  id: totrans-split-977
  prefs: []
  type: TYPE_NORMAL
- en: Piuri
  id: totrans-split-978
  prefs: []
  type: TYPE_NORMAL
- en: G
  id: totrans-split-979
  prefs: []
  type: TYPE_NORMAL
- en: ', Zocchi'
  id: totrans-split-980
  prefs: []
  type: TYPE_NORMAL
- en: M , Della Porta
  id: totrans-split-981
  prefs: []
  type: TYPE_NORMAL
- en: M , et al.
  id: totrans-split-982
  prefs: []
  type: TYPE_NORMAL
- en: Magnesium in obesity, metabolic syndrome, and type 2 diabetes
  id: totrans-split-983
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-984
  prefs: []
  type: TYPE_NORMAL
- en: Nutrients
  id: totrans-split-985
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-986
  prefs: []
  type: TYPE_NORMAL
- en: '2021'
  id: totrans-split-987
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-988
  prefs: []
  type: TYPE_NORMAL
- en: '13'
  id: totrans-split-989
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-990
  prefs: []
  type: TYPE_NORMAL
- en: '2'
  id: totrans-split-991
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-992
  prefs: []
  type: TYPE_NORMAL
- en: '320'
  id: totrans-split-993
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-994
  prefs: []
  type: TYPE_NORMAL
- en: '20'
  id: totrans-split-995
  prefs: []
  type: TYPE_NORMAL
- en: Pelczyńska
  id: totrans-split-996
  prefs: []
  type: TYPE_NORMAL
- en: M
  id: totrans-split-997
  prefs: []
  type: TYPE_NORMAL
- en: ', Moszak'
  id: totrans-split-998
  prefs: []
  type: TYPE_NORMAL
- en: M , Bogdański
  id: totrans-split-999
  prefs: []
  type: TYPE_NORMAL
- en: P .
  id: totrans-split-1000
  prefs: []
  type: TYPE_NORMAL
- en: The role of magnesium in the pathogenesis of metabolic disorders
  id: totrans-split-1001
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1002
  prefs: []
  type: TYPE_NORMAL
- en: Nutrients
  id: totrans-split-1003
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1004
  prefs: []
  type: TYPE_NORMAL
- en: '2022'
  id: totrans-split-1005
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1006
  prefs: []
  type: TYPE_NORMAL
- en: '14'
  id: totrans-split-1007
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1008
  prefs: []
  type: TYPE_NORMAL
- en: '9'
  id: totrans-split-1009
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1010
  prefs: []
  type: TYPE_NORMAL
- en: '1714'
  id: totrans-split-1011
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1012
  prefs: []
  type: TYPE_NORMAL
- en: '21'
  id: totrans-split-1013
  prefs: []
  type: TYPE_NORMAL
- en: Rodríguez-Morán
  id: totrans-split-1014
  prefs: []
  type: TYPE_NORMAL
- en: M
  id: totrans-split-1015
  prefs: []
  type: TYPE_NORMAL
- en: ', Simental-Mendía'
  id: totrans-split-1016
  prefs: []
  type: TYPE_NORMAL
- en: LE , Gamboa-Gómez
  id: totrans-split-1017
  prefs: []
  type: TYPE_NORMAL
- en: CI , Guerrero-Romero
  id: totrans-split-1018
  prefs: []
  type: TYPE_NORMAL
- en: F .
  id: totrans-split-1019
  prefs: []
  type: TYPE_NORMAL
- en: 'Oral magnesium supplementation and metabolic syndrome: a randomized double-blind
    placebo-controlled clinical trial'
  id: totrans-split-1020
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1021
  prefs: []
  type: TYPE_NORMAL
- en: Adv Chronic Kidney Dis
  id: totrans-split-1022
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1023
  prefs: []
  type: TYPE_NORMAL
- en: '2018'
  id: totrans-split-1024
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1025
  prefs: []
  type: TYPE_NORMAL
- en: '25'
  id: totrans-split-1026
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1027
  prefs: []
  type: TYPE_NORMAL
- en: '3'
  id: totrans-split-1028
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1029
  prefs: []
  type: TYPE_NORMAL
- en: '261'
  id: totrans-split-1030
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1031
  prefs: []
  type: TYPE_NORMAL
- en: '266'
  id: totrans-split-1032
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1033
  prefs: []
  type: TYPE_NORMAL
- en: '22'
  id: totrans-split-1034
  prefs: []
  type: TYPE_NORMAL
- en: Ismail
  id: totrans-split-1035
  prefs: []
  type: TYPE_NORMAL
- en: Y
  id: totrans-split-1036
  prefs: []
  type: TYPE_NORMAL
- en: ', Ismail'
  id: totrans-split-1037
  prefs: []
  type: TYPE_NORMAL
- en: AA , Ismail
  id: totrans-split-1038
  prefs: []
  type: TYPE_NORMAL
- en: AAA .
  id: totrans-split-1039
  prefs: []
  type: TYPE_NORMAL
- en: The underestimated problem of using serum magnesium measurements to exclude
    magnesium deficiency in adults; a health warning is needed for “normal” results
  id: totrans-split-1040
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1041
  prefs: []
  type: TYPE_NORMAL
- en: Clin Chem Lab Med
  id: totrans-split-1042
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1043
  prefs: []
  type: TYPE_NORMAL
- en: '2010'
  id: totrans-split-1044
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1045
  prefs: []
  type: TYPE_NORMAL
- en: '48'
  id: totrans-split-1046
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1047
  prefs: []
  type: TYPE_NORMAL
- en: '3'
  id: totrans-split-1048
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1049
  prefs: []
  type: TYPE_NORMAL
- en: '323'
  id: totrans-split-1050
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1051
  prefs: []
  type: TYPE_NORMAL
- en: '327'
  id: totrans-split-1052
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1053
  prefs: []
  type: TYPE_NORMAL
- en: '23'
  id: totrans-split-1054
  prefs: []
  type: TYPE_NORMAL
- en: Ismail
  id: totrans-split-1055
  prefs: []
  type: TYPE_NORMAL
- en: A
  id: totrans-split-1056
  prefs: []
  type: TYPE_NORMAL
- en: ', Ismail'
  id: totrans-split-1057
  prefs: []
  type: TYPE_NORMAL
- en: Y , Ismail
  id: totrans-split-1058
  prefs: []
  type: TYPE_NORMAL
- en: AA .
  id: totrans-split-1059
  prefs: []
  type: TYPE_NORMAL
- en: Chronic magnesium deficiency and human disease; time for reappraisal
  id: totrans-split-1060
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1061
  prefs: []
  type: TYPE_NORMAL
- en: QJM
  id: totrans-split-1062
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1063
  prefs: []
  type: TYPE_NORMAL
- en: '2018'
  id: totrans-split-1064
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1065
  prefs: []
  type: TYPE_NORMAL
- en: '111'
  id: totrans-split-1066
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1067
  prefs: []
  type: TYPE_NORMAL
- en: '11'
  id: totrans-split-1068
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1069
  prefs: []
  type: TYPE_NORMAL
- en: '759'
  id: totrans-split-1070
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1071
  prefs: []
  type: TYPE_NORMAL
- en: '763'
  id: totrans-split-1072
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1073
  prefs: []
  type: TYPE_NORMAL
- en: '24'
  id: totrans-split-1074
  prefs: []
  type: TYPE_NORMAL
- en: Elin
  id: totrans-split-1075
  prefs: []
  type: TYPE_NORMAL
- en: RJ
  id: totrans-split-1076
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1077
  prefs: []
  type: TYPE_NORMAL
- en: 'Magnesium: the fifth but forgotten electrolyte'
  id: totrans-split-1078
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1079
  prefs: []
  type: TYPE_NORMAL
- en: Am J Clin Pathol
  id: totrans-split-1080
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1081
  prefs: []
  type: TYPE_NORMAL
- en: '1994'
  id: totrans-split-1082
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1083
  prefs: []
  type: TYPE_NORMAL
- en: '102'
  id: totrans-split-1084
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1085
  prefs: []
  type: TYPE_NORMAL
- en: '5'
  id: totrans-split-1086
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1087
  prefs: []
  type: TYPE_NORMAL
- en: '616'
  id: totrans-split-1088
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1089
  prefs: []
  type: TYPE_NORMAL
- en: '622'
  id: totrans-split-1090
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1091
  prefs: []
  type: TYPE_NORMAL
- en: '25'
  id: totrans-split-1092
  prefs: []
  type: TYPE_NORMAL
- en: Elisaf
  id: totrans-split-1093
  prefs: []
  type: TYPE_NORMAL
- en: M
  id: totrans-split-1094
  prefs: []
  type: TYPE_NORMAL
- en: ', Panteli'
  id: totrans-split-1095
  prefs: []
  type: TYPE_NORMAL
- en: K , Theodorou
  id: totrans-split-1096
  prefs: []
  type: TYPE_NORMAL
- en: J , Siamopoulos
  id: totrans-split-1097
  prefs: []
  type: TYPE_NORMAL
- en: KC .
  id: totrans-split-1098
  prefs: []
  type: TYPE_NORMAL
- en: Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia
  id: totrans-split-1099
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1100
  prefs: []
  type: TYPE_NORMAL
- en: Magnes Res
  id: totrans-split-1101
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1102
  prefs: []
  type: TYPE_NORMAL
- en: '1997'
  id: totrans-split-1103
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1104
  prefs: []
  type: TYPE_NORMAL
- en: '10'
  id: totrans-split-1105
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1106
  prefs: []
  type: TYPE_NORMAL
- en: '4'
  id: totrans-split-1107
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1108
  prefs: []
  type: TYPE_NORMAL
- en: '315'
  id: totrans-split-1109
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1110
  prefs: []
  type: TYPE_NORMAL
- en: '320'
  id: totrans-split-1111
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1112
  prefs: []
  type: TYPE_NORMAL
- en: '26'
  id: totrans-split-1113
  prefs: []
  type: TYPE_NORMAL
- en: Zhang
  id: totrans-split-1114
  prefs: []
  type: TYPE_NORMAL
- en: X
  id: totrans-split-1115
  prefs: []
  type: TYPE_NORMAL
- en: ', Del Gobbo'
  id: totrans-split-1116
  prefs: []
  type: TYPE_NORMAL
- en: LC , Hruby
  id: totrans-split-1117
  prefs: []
  type: TYPE_NORMAL
- en: A , et al.
  id: totrans-split-1118
  prefs: []
  type: TYPE_NORMAL
- en: The circulating concentration and 24-h urine excretion of magnesium dose- and
    time-dependently respond to oral magnesium supplementation in a meta-analysis
    of randomized controlled trials
  id: totrans-split-1119
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1120
  prefs: []
  type: TYPE_NORMAL
- en: J Nutr
  id: totrans-split-1121
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1122
  prefs: []
  type: TYPE_NORMAL
- en: '2016'
  id: totrans-split-1123
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1124
  prefs: []
  type: TYPE_NORMAL
- en: '146'
  id: totrans-split-1125
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1126
  prefs: []
  type: TYPE_NORMAL
- en: '3'
  id: totrans-split-1127
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1128
  prefs: []
  type: TYPE_NORMAL
- en: '595'
  id: totrans-split-1129
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1130
  prefs: []
  type: TYPE_NORMAL
- en: '602'
  id: totrans-split-1131
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1132
  prefs: []
  type: TYPE_NORMAL
- en: '27'
  id: totrans-split-1133
  prefs: []
  type: TYPE_NORMAL
- en: Ryzen
  id: totrans-split-1134
  prefs: []
  type: TYPE_NORMAL
- en: E
  id: totrans-split-1135
  prefs: []
  type: TYPE_NORMAL
- en: ', Elbaum'
  id: totrans-split-1136
  prefs: []
  type: TYPE_NORMAL
- en: N , Singer
  id: totrans-split-1137
  prefs: []
  type: TYPE_NORMAL
- en: FR , Rude
  id: totrans-split-1138
  prefs: []
  type: TYPE_NORMAL
- en: RK .
  id: totrans-split-1139
  prefs: []
  type: TYPE_NORMAL
- en: Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency
  id: totrans-split-1140
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1141
  prefs: []
  type: TYPE_NORMAL
- en: Magnesium
  id: totrans-split-1142
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1143
  prefs: []
  type: TYPE_NORMAL
- en: '1985'
  id: totrans-split-1144
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1145
  prefs: []
  type: TYPE_NORMAL
- en: '4'
  id: totrans-split-1146
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1147
  prefs: []
  type: TYPE_NORMAL
- en: 2–3
  id: totrans-split-1148
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1149
  prefs: []
  type: TYPE_NORMAL
- en: '137'
  id: totrans-split-1150
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1151
  prefs: []
  type: TYPE_NORMAL
- en: '147'
  id: totrans-split-1152
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1153
  prefs: []
  type: TYPE_NORMAL
- en: '28'
  id: totrans-split-1154
  prefs: []
  type: TYPE_NORMAL
- en: Arnaud
  id: totrans-split-1155
  prefs: []
  type: TYPE_NORMAL
- en: MJ
  id: totrans-split-1156
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1157
  prefs: []
  type: TYPE_NORMAL
- en: Update on the assessment of magnesium status
  id: totrans-split-1158
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1159
  prefs: []
  type: TYPE_NORMAL
- en: Br J Nutr
  id: totrans-split-1160
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1161
  prefs: []
  type: TYPE_NORMAL
- en: '2008'
  id: totrans-split-1162
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1163
  prefs: []
  type: TYPE_NORMAL
- en: '99'
  id: totrans-split-1164
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1165
  prefs: []
  type: TYPE_NORMAL
- en: Suppl 3
  id: totrans-split-1166
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1167
  prefs: []
  type: TYPE_NORMAL
- en: S24
  id: totrans-split-1168
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1169
  prefs: []
  type: TYPE_NORMAL
- en: S36
  id: totrans-split-1170
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1171
  prefs: []
  type: TYPE_NORMAL
- en: '29'
  id: totrans-split-1172
  prefs: []
  type: TYPE_NORMAL
- en: Rubenowitz
  id: totrans-split-1173
  prefs: []
  type: TYPE_NORMAL
- en: E
  id: totrans-split-1174
  prefs: []
  type: TYPE_NORMAL
- en: ', Axelsson'
  id: totrans-split-1175
  prefs: []
  type: TYPE_NORMAL
- en: G , Rylander
  id: totrans-split-1176
  prefs: []
  type: TYPE_NORMAL
- en: R .
  id: totrans-split-1177
  prefs: []
  type: TYPE_NORMAL
- en: Magnesium in drinking water and body magnesium status measured using an oral
    loading test
  id: totrans-split-1178
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1179
  prefs: []
  type: TYPE_NORMAL
- en: Scand J Clin Lab Invest
  id: totrans-split-1180
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1181
  prefs: []
  type: TYPE_NORMAL
- en: '1998'
  id: totrans-split-1182
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1183
  prefs: []
  type: TYPE_NORMAL
- en: '58'
  id: totrans-split-1184
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1185
  prefs: []
  type: TYPE_NORMAL
- en: '5'
  id: totrans-split-1186
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1187
  prefs: []
  type: TYPE_NORMAL
- en: '423'
  id: totrans-split-1188
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1189
  prefs: []
  type: TYPE_NORMAL
- en: '428'
  id: totrans-split-1190
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1191
  prefs: []
  type: TYPE_NORMAL
- en: '30'
  id: totrans-split-1192
  prefs: []
  type: TYPE_NORMAL
- en: Rylander
  id: totrans-split-1193
  prefs: []
  type: TYPE_NORMAL
- en: R
  id: totrans-split-1194
  prefs: []
  type: TYPE_NORMAL
- en: ', Mégevand'
  id: totrans-split-1195
  prefs: []
  type: TYPE_NORMAL
- en: Y , Lasserre
  id: totrans-split-1196
  prefs: []
  type: TYPE_NORMAL
- en: B , Amstutz
  id: totrans-split-1197
  prefs: []
  type: TYPE_NORMAL
- en: W , Granbom
  id: totrans-split-1198
  prefs: []
  type: TYPE_NORMAL
- en: S .
  id: totrans-split-1199
  prefs: []
  type: TYPE_NORMAL
- en: Moderate alcohol consumption and urinary excretion of magnesium and calcium
  id: totrans-split-1200
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1201
  prefs: []
  type: TYPE_NORMAL
- en: Scand J Clin Lab Invest
  id: totrans-split-1202
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1203
  prefs: []
  type: TYPE_NORMAL
- en: '2001'
  id: totrans-split-1204
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1205
  prefs: []
  type: TYPE_NORMAL
- en: '61'
  id: totrans-split-1206
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1207
  prefs: []
  type: TYPE_NORMAL
- en: '5'
  id: totrans-split-1208
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1209
  prefs: []
  type: TYPE_NORMAL
- en: '401'
  id: totrans-split-1210
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1211
  prefs: []
  type: TYPE_NORMAL
- en: '405'
  id: totrans-split-1212
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1213
  prefs: []
  type: TYPE_NORMAL
- en: '31'
  id: totrans-split-1214
  prefs: []
  type: TYPE_NORMAL
- en: Gröber
  id: totrans-split-1215
  prefs: []
  type: TYPE_NORMAL
- en: U
  id: totrans-split-1216
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1217
  prefs: []
  type: TYPE_NORMAL
- en: Magnesium and drugs
  id: totrans-split-1218
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1219
  prefs: []
  type: TYPE_NORMAL
- en: Int J Mol Sci
  id: totrans-split-1220
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1221
  prefs: []
  type: TYPE_NORMAL
- en: '2019'
  id: totrans-split-1222
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1223
  prefs: []
  type: TYPE_NORMAL
- en: '20'
  id: totrans-split-1224
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1225
  prefs: []
  type: TYPE_NORMAL
- en: '9'
  id: totrans-split-1226
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1227
  prefs: []
  type: TYPE_NORMAL
- en: '2094'
  id: totrans-split-1228
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1229
  prefs: []
  type: TYPE_NORMAL
- en: '32'
  id: totrans-split-1230
  prefs: []
  type: TYPE_NORMAL
- en: William
  id: totrans-split-1231
  prefs: []
  type: TYPE_NORMAL
- en: JH
  id: totrans-split-1232
  prefs: []
  type: TYPE_NORMAL
- en: ', Danziger'
  id: totrans-split-1233
  prefs: []
  type: TYPE_NORMAL
- en: J .
  id: totrans-split-1234
  prefs: []
  type: TYPE_NORMAL
- en: 'Proton-pump inhibitor-induced hypomagnesemia: current research and proposed
    mechanisms'
  id: totrans-split-1235
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1236
  prefs: []
  type: TYPE_NORMAL
- en: World J Nephrol
  id: totrans-split-1237
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1238
  prefs: []
  type: TYPE_NORMAL
- en: '2016'
  id: totrans-split-1239
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1240
  prefs: []
  type: TYPE_NORMAL
- en: '5'
  id: totrans-split-1241
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1242
  prefs: []
  type: TYPE_NORMAL
- en: '2'
  id: totrans-split-1243
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1244
  prefs: []
  type: TYPE_NORMAL
- en: '152'
  id: totrans-split-1245
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1246
  prefs: []
  type: TYPE_NORMAL
- en: '157'
  id: totrans-split-1247
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1248
  prefs: []
  type: TYPE_NORMAL
- en: '33'
  id: totrans-split-1249
  prefs: []
  type: TYPE_NORMAL
- en: de Baaij
  id: totrans-split-1250
  prefs: []
  type: TYPE_NORMAL
- en: JH
  id: totrans-split-1251
  prefs: []
  type: TYPE_NORMAL
- en: ', Hoenderop'
  id: totrans-split-1252
  prefs: []
  type: TYPE_NORMAL
- en: JG , Bindels
  id: totrans-split-1253
  prefs: []
  type: TYPE_NORMAL
- en: RJ .
  id: totrans-split-1254
  prefs: []
  type: TYPE_NORMAL
- en: 'Magnesium in man: implications for health and disease'
  id: totrans-split-1255
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1256
  prefs: []
  type: TYPE_NORMAL
- en: Physiol Rev
  id: totrans-split-1257
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1258
  prefs: []
  type: TYPE_NORMAL
- en: '2015'
  id: totrans-split-1259
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1260
  prefs: []
  type: TYPE_NORMAL
- en: '95'
  id: totrans-split-1261
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1262
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1263
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1264
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1265
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1266
  prefs: []
  type: TYPE_NORMAL
- en: '46'
  id: totrans-split-1267
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1268
  prefs: []
  type: TYPE_NORMAL
- en: '34'
  id: totrans-split-1269
  prefs: []
  type: TYPE_NORMAL
- en: Sarrafzadegan
  id: totrans-split-1270
  prefs: []
  type: TYPE_NORMAL
- en: N
  id: totrans-split-1271
  prefs: []
  type: TYPE_NORMAL
- en: ', Khosravi-Boroujeni'
  id: totrans-split-1272
  prefs: []
  type: TYPE_NORMAL
- en: H , Lotfizadeh
  id: totrans-split-1273
  prefs: []
  type: TYPE_NORMAL
- en: M , Pourmogaddas
  id: totrans-split-1274
  prefs: []
  type: TYPE_NORMAL
- en: A , Salehi-Abargouei
  id: totrans-split-1275
  prefs: []
  type: TYPE_NORMAL
- en: A .
  id: totrans-split-1276
  prefs: []
  type: TYPE_NORMAL
- en: 'Magnesium status and the metabolic syndrome: a systematic review and meta-analysis'
  id: totrans-split-1277
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1278
  prefs: []
  type: TYPE_NORMAL
- en: Nutrition
  id: totrans-split-1279
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1280
  prefs: []
  type: TYPE_NORMAL
- en: '2016'
  id: totrans-split-1281
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1282
  prefs: []
  type: TYPE_NORMAL
- en: '32'
  id: totrans-split-1283
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1284
  prefs: []
  type: TYPE_NORMAL
- en: '4'
  id: totrans-split-1285
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1286
  prefs: []
  type: TYPE_NORMAL
- en: '409'
  id: totrans-split-1287
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1288
  prefs: []
  type: TYPE_NORMAL
- en: '417'
  id: totrans-split-1289
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1290
  prefs: []
  type: TYPE_NORMAL
- en: '35'
  id: totrans-split-1291
  prefs: []
  type: TYPE_NORMAL
- en: Song
  id: totrans-split-1292
  prefs: []
  type: TYPE_NORMAL
- en: Y
  id: totrans-split-1293
  prefs: []
  type: TYPE_NORMAL
- en: ', Li'
  id: totrans-split-1294
  prefs: []
  type: TYPE_NORMAL
- en: TY , van Dam
  id: totrans-split-1295
  prefs: []
  type: TYPE_NORMAL
- en: RM , Manson
  id: totrans-split-1296
  prefs: []
  type: TYPE_NORMAL
- en: JE , Hu
  id: totrans-split-1297
  prefs: []
  type: TYPE_NORMAL
- en: FB .
  id: totrans-split-1298
  prefs: []
  type: TYPE_NORMAL
- en: Magnesium intake and plasma concentrations of markers of systemic inflammation
    and endothelial dysfunction in women
  id: totrans-split-1299
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1300
  prefs: []
  type: TYPE_NORMAL
- en: Am J Clin Nutr
  id: totrans-split-1301
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1302
  prefs: []
  type: TYPE_NORMAL
- en: '2007'
  id: totrans-split-1303
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1304
  prefs: []
  type: TYPE_NORMAL
- en: '85'
  id: totrans-split-1305
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1306
  prefs: []
  type: TYPE_NORMAL
- en: '4'
  id: totrans-split-1307
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1308
  prefs: []
  type: TYPE_NORMAL
- en: '1068'
  id: totrans-split-1309
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1310
  prefs: []
  type: TYPE_NORMAL
- en: '1074'
  id: totrans-split-1311
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1312
  prefs: []
  type: TYPE_NORMAL
- en: '36'
  id: totrans-split-1313
  prefs: []
  type: TYPE_NORMAL
- en: Han
  id: totrans-split-1314
  prefs: []
  type: TYPE_NORMAL
- en: H
  id: totrans-split-1315
  prefs: []
  type: TYPE_NORMAL
- en: ', Fang'
  id: totrans-split-1316
  prefs: []
  type: TYPE_NORMAL
- en: X , Wei
  id: totrans-split-1317
  prefs: []
  type: TYPE_NORMAL
- en: X , et al.
  id: totrans-split-1318
  prefs: []
  type: TYPE_NORMAL
- en: 'Dose-response relationship between dietary magnesium intake, serum magnesium
    concentration and risk of hypertension: a systematic review and meta-analysis
    of prospective cohort studies'
  id: totrans-split-1319
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1320
  prefs: []
  type: TYPE_NORMAL
- en: Nutr J
  id: totrans-split-1321
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1322
  prefs: []
  type: TYPE_NORMAL
- en: '2017'
  id: totrans-split-1323
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1324
  prefs: []
  type: TYPE_NORMAL
- en: '16'
  id: totrans-split-1325
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1326
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1327
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1328
  prefs: []
  type: TYPE_NORMAL
- en: '26'
  id: totrans-split-1329
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1330
  prefs: []
  type: TYPE_NORMAL
- en: '37'
  id: totrans-split-1331
  prefs: []
  type: TYPE_NORMAL
- en: Găman
  id: totrans-split-1332
  prefs: []
  type: TYPE_NORMAL
- en: M-A
  id: totrans-split-1333
  prefs: []
  type: TYPE_NORMAL
- en: ', Dobrică'
  id: totrans-split-1334
  prefs: []
  type: TYPE_NORMAL
- en: E-C , Cozma
  id: totrans-split-1335
  prefs: []
  type: TYPE_NORMAL
- en: M-A , et al.
  id: totrans-split-1336
  prefs: []
  type: TYPE_NORMAL
- en: 'Crosstalk of magnesium and serum lipids in dyslipidemia and associated disorders:
    a systematic review'
  id: totrans-split-1337
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1338
  prefs: []
  type: TYPE_NORMAL
- en: Nutrients
  id: totrans-split-1339
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1340
  prefs: []
  type: TYPE_NORMAL
- en: '2021'
  id: totrans-split-1341
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1342
  prefs: []
  type: TYPE_NORMAL
- en: '13'
  id: totrans-split-1343
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1344
  prefs: []
  type: TYPE_NORMAL
- en: '5'
  id: totrans-split-1345
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1346
  prefs: []
  type: TYPE_NORMAL
- en: '1411'
  id: totrans-split-1347
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1348
  prefs: []
  type: TYPE_NORMAL
- en: '38'
  id: totrans-split-1349
  prefs: []
  type: TYPE_NORMAL
- en: Nik
  id: totrans-split-1350
  prefs: []
  type: TYPE_NORMAL
- en: WNFHW
  id: totrans-split-1351
  prefs: []
  type: TYPE_NORMAL
- en: ', Zulkeflee'
  id: totrans-split-1352
  prefs: []
  type: TYPE_NORMAL
- en: HA , Ab Rahim
  id: totrans-split-1353
  prefs: []
  type: TYPE_NORMAL
- en: SN , Tuan Ismail
  id: totrans-split-1354
  prefs: []
  type: TYPE_NORMAL
- en: TST .
  id: totrans-split-1355
  prefs: []
  type: TYPE_NORMAL
- en: Association of vitamin D and magnesium with insulin sensitivity and their influence
    on glycemic control
  id: totrans-split-1356
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1357
  prefs: []
  type: TYPE_NORMAL
- en: World J Diabetes
  id: totrans-split-1358
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1359
  prefs: []
  type: TYPE_NORMAL
- en: '2023'
  id: totrans-split-1360
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1361
  prefs: []
  type: TYPE_NORMAL
- en: '14'
  id: totrans-split-1362
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1363
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1364
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1365
  prefs: []
  type: TYPE_NORMAL
- en: '26'
  id: totrans-split-1366
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1367
  prefs: []
  type: TYPE_NORMAL
- en: '34'
  id: totrans-split-1368
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1369
  prefs: []
  type: TYPE_NORMAL
- en: '39'
  id: totrans-split-1370
  prefs: []
  type: TYPE_NORMAL
- en: ELDerawi
  id: totrans-split-1371
  prefs: []
  type: TYPE_NORMAL
- en: WA
  id: totrans-split-1372
  prefs: []
  type: TYPE_NORMAL
- en: ', Naser'
  id: totrans-split-1373
  prefs: []
  type: TYPE_NORMAL
- en: IA , Taleb
  id: totrans-split-1374
  prefs: []
  type: TYPE_NORMAL
- en: MH , Abutair
  id: totrans-split-1375
  prefs: []
  type: TYPE_NORMAL
- en: AS .
  id: totrans-split-1376
  prefs: []
  type: TYPE_NORMAL
- en: The effects of oral magnesium supplementation on glycemic response among type
    2 diabetes patients
  id: totrans-split-1377
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1378
  prefs: []
  type: TYPE_NORMAL
- en: Nutrients
  id: totrans-split-1379
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1380
  prefs: []
  type: TYPE_NORMAL
- en: '2018'
  id: totrans-split-1381
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1382
  prefs: []
  type: TYPE_NORMAL
- en: '11'
  id: totrans-split-1383
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1384
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1385
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1386
  prefs: []
  type: TYPE_NORMAL
- en: '44'
  id: totrans-split-1387
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1388
  prefs: []
  type: TYPE_NORMAL
- en: '40'
  id: totrans-split-1389
  prefs: []
  type: TYPE_NORMAL
- en: Ghasemi
  id: totrans-split-1390
  prefs: []
  type: TYPE_NORMAL
- en: A
  id: totrans-split-1391
  prefs: []
  type: TYPE_NORMAL
- en: ', Zahediasl'
  id: totrans-split-1392
  prefs: []
  type: TYPE_NORMAL
- en: S , Syedmoradi
  id: totrans-split-1393
  prefs: []
  type: TYPE_NORMAL
- en: L , Azizi
  id: totrans-split-1394
  prefs: []
  type: TYPE_NORMAL
- en: F .
  id: totrans-split-1395
  prefs: []
  type: TYPE_NORMAL
- en: Low serum magnesium levels in elderly subjects with metabolic syndrome
  id: totrans-split-1396
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1397
  prefs: []
  type: TYPE_NORMAL
- en: Biol Trace Elem Res
  id: totrans-split-1398
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1399
  prefs: []
  type: TYPE_NORMAL
- en: '2010'
  id: totrans-split-1400
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1401
  prefs: []
  type: TYPE_NORMAL
- en: '136'
  id: totrans-split-1402
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1403
  prefs: []
  type: TYPE_NORMAL
- en: '1'
  id: totrans-split-1404
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1405
  prefs: []
  type: TYPE_NORMAL
- en: '18'
  id: totrans-split-1406
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1407
  prefs: []
  type: TYPE_NORMAL
- en: '25'
  id: totrans-split-1408
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1409
  prefs: []
  type: TYPE_NORMAL
- en: '41'
  id: totrans-split-1410
  prefs: []
  type: TYPE_NORMAL
- en: Simmons
  id: totrans-split-1411
  prefs: []
  type: TYPE_NORMAL
- en: D
  id: totrans-split-1412
  prefs: []
  type: TYPE_NORMAL
- en: ', Joshi'
  id: totrans-split-1413
  prefs: []
  type: TYPE_NORMAL
- en: S , Shaw
  id: totrans-split-1414
  prefs: []
  type: TYPE_NORMAL
- en: J .
  id: totrans-split-1415
  prefs: []
  type: TYPE_NORMAL
- en: 'Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the
    metabolic syndrome'
  id: totrans-split-1416
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1417
  prefs: []
  type: TYPE_NORMAL
- en: Diabetes Res Clin Pract
  id: totrans-split-1418
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1419
  prefs: []
  type: TYPE_NORMAL
- en: '2010'
  id: totrans-split-1420
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1421
  prefs: []
  type: TYPE_NORMAL
- en: '87'
  id: totrans-split-1422
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1423
  prefs: []
  type: TYPE_NORMAL
- en: '2'
  id: totrans-split-1424
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1425
  prefs: []
  type: TYPE_NORMAL
- en: '261'
  id: totrans-split-1426
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1427
  prefs: []
  type: TYPE_NORMAL
- en: '266'
  id: totrans-split-1428
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1429
  prefs: []
  type: TYPE_NORMAL
- en: '42'
  id: totrans-split-1430
  prefs: []
  type: TYPE_NORMAL
- en: Yu
  id: totrans-split-1431
  prefs: []
  type: TYPE_NORMAL
- en: Y
  id: totrans-split-1432
  prefs: []
  type: TYPE_NORMAL
- en: ', Cai'
  id: totrans-split-1433
  prefs: []
  type: TYPE_NORMAL
- en: Z , Zheng
  id: totrans-split-1434
  prefs: []
  type: TYPE_NORMAL
- en: J , et al.
  id: totrans-split-1435
  prefs: []
  type: TYPE_NORMAL
- en: Serum levels of polyunsaturated fatty acids are low in Chinese men with metabolic
    syndrome, whereas serum levels of saturated fatty acids, zinc, and magnesium are
    high
  id: totrans-split-1436
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1437
  prefs: []
  type: TYPE_NORMAL
- en: Nutr Res
  id: totrans-split-1438
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1439
  prefs: []
  type: TYPE_NORMAL
- en: '2012'
  id: totrans-split-1440
  prefs: []
  type: TYPE_NORMAL
- en: ;
  id: totrans-split-1441
  prefs: []
  type: TYPE_NORMAL
- en: '32'
  id: totrans-split-1442
  prefs: []
  type: TYPE_NORMAL
- en: (
  id: totrans-split-1443
  prefs: []
  type: TYPE_NORMAL
- en: '2'
  id: totrans-split-1444
  prefs: []
  type: TYPE_NORMAL
- en: '):'
  id: totrans-split-1445
  prefs: []
  type: TYPE_NORMAL
- en: '71'
  id: totrans-split-1446
  prefs: []
  type: TYPE_NORMAL
- en: ‐
  id: totrans-split-1447
  prefs: []
  type: TYPE_NORMAL
- en: '77'
  id: totrans-split-1448
  prefs: []
  type: TYPE_NORMAL
- en: .
  id: totrans-split-1449
  prefs: []
  type: TYPE_NORMAL
- en: Abbreviations
  id: totrans-split-1450
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
- en: ALT
  id: totrans-split-1451
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: AST
  id: totrans-split-1452
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: BMI
  id: totrans-split-1453
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Ca
  id: totrans-split-1454
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: DBP
  id: totrans-split-1455
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: eGFR
  id: totrans-split-1456
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: estimated glomerular filtration rate
  id: totrans-split-1457
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: FEMg
  id: totrans-split-1458
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: fractional excretion of magnesium
  id: totrans-split-1459
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: HbA[1c]
  id: totrans-split-1460
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: HDL-C
  id: totrans-split-1461
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: high-density lipoprotein cholesterol
  id: totrans-split-1462
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: HOMA-IR
  id: totrans-split-1463
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: homeostatic model assessment for insulin resistance
  id: totrans-split-1464
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: LDL-c
  id: totrans-split-1465
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: low-density lipoprotein cholesterol
  id: totrans-split-1466
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: MDS
  id: totrans-split-1467
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: magnesium depletion score
  id: totrans-split-1468
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: MetS
  id: totrans-split-1469
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: NCEP-ATP III
  id: totrans-split-1470
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: National Cholesterol Education Program Adult Treatment Panel III Criteria
  id: totrans-split-1471
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: NHANES
  id: totrans-split-1472
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: National Health and Nutrition Examination Survey
  id: totrans-split-1473
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
- en: OR
  id: totrans-split-1474
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: PPI
  id: totrans-split-1475
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: RCS
  id: totrans-split-1476
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: SBP
  id: totrans-split-1477
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: TC
  id: totrans-split-1478
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: TGs
  id: totrans-split-1479
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: © The Author(s) 2024\. Published by Oxford University Press on behalf of the
    Endocrine Society.
  id: totrans-split-1480
  prefs: []
  type: TYPE_NORMAL
- en: This is an Open Access article distributed under the terms of the Creative Commons
    Attribution License (
  id: totrans-split-1481
  prefs: []
  type: TYPE_NORMAL
  zh: 这是一篇根据创作共用署名 4.0 国际许可协议进行发布的开放获取文章。
- en: '[https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)'
  id: totrans-split-1482
  prefs: []
  type: TYPE_NORMAL
  zh: '[https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)'
- en: ), which permits unrestricted reuse, distribution, and reproduction in any medium,
    provided the original work is properly cited.
  id: totrans-split-1483
  prefs: []
  type: TYPE_NORMAL
  zh: ), 允许在任何媒介中无限制地重复使用、分发和复制，只要原始作品得到适当引用。
